var title_f4_26_4512="Truncal rash in measles";
var content_f4_26_4512=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F57093&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F57093&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Measles exanthem",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 332px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blanching erythematous rash with some confluent areas on the trunk in a patient with measles.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright Dr. Michael Bennish; reproduced with his permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4512=[""].join("\n");
var outline_f4_26_4512=null;
var title_f4_26_4513="Idrocilamide: International drug information";
var content_f4_26_4513=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"10\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Idrocilamide: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4304049\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Srilane (BE, FR, LU);",
"     </li>",
"     <li>",
"      Talval (CH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1978990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Skeletal Muscle Relaxant",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1978993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of painful muscle spasms associated with musculoskeletal conditions",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1978989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Topical: Apply to affected area 1-3 times/day",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1978992\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cream: 5% (50 g, 100 g)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10392 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-D487AFE9F4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4513=[""].join("\n");
var outline_f4_26_4513=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4304049\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978990\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978993\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978989\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821175\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978992\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10392\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10392|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_26_4514="Patient information: Ventricular septal defect (The Basics)";
var content_f4_26_4514=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83036\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/60/12224\">",
"         Atrial and ventricular septal defects",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?24/51/25395\">",
"         Patient information: ECG and stress test (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/42/36514\">",
"         Patient information: Heart murmurs (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Ventricular septal defect (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/ventricular-septal-defect-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H12130529\">",
"      <span class=\"h1\">",
"       What is ventricular septal defect?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Ventricular septal defect (also called &ldquo;VSD&rdquo;) is a hole between 2 sections of the heart. The heart is divided into 4 sections, called &ldquo;chambers.&rdquo; People with a VSD have a hole between the 2 lower chambers, called the &ldquo;ventricles&rdquo; (",
"      <a class=\"graphic graphic_figure graphicRef83029 \" href=\"UTD.htm?11/60/12224\">",
"       figure 1",
"      </a>",
"      ). VSD changes the way blood flows through the heart. If the VSD is large, this can cause serious health problems.",
"     </p>",
"     <p>",
"      VSD is a common heart problem. A person who has VSD was born with it. He or she might only have VSD, or also have other heart problems.",
"     </p>",
"     <p>",
"      A VSD causes a heart murmur. This is an extra sound doctors or nurses hear when they listen to the heart with a stethoscope.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12130544\">",
"      <span class=\"h1\">",
"       What are the symptoms of ventricular septal defect?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A baby or child who has a small VSD might not have any symptoms. If the VSD is medium or large, it can cause symptoms by the time a baby is 2 to 8 weeks old. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Heartbeat that seems faster than usual",
"       </li>",
"       <li>",
"        Breathing that is fast, noisy, or both &nbsp;",
"       </li>",
"       <li>",
"        Not gaining weight or growing as quickly as other babies",
"       </li>",
"       <li>",
"        Acting hungry, but having trouble eating -- Babies with VSD can get tired and sweaty when they try to eat.",
"       </li>",
"       <li>",
"        Pale skin &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12130559\">",
"      <span class=\"h1\">",
"       Should my child see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If a baby has VSD, a doctor or nurse might find it soon after birth. But this does not always happen. See the doctor or nurse if your baby has any of the symptoms of VSD. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12130574\">",
"      <span class=\"h1\">",
"       Will my child need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If the doctor or nurse thinks your child might have a VSD, he or she will probably order tests. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        An electrocardiogram (ECG or EKG)&nbsp;&mdash; This test measures the electrical activity in the heart. It might show a pattern of abnormal electrical activity that is common in people who have VSD.",
"       </li>",
"       <li>",
"        A chest X-ray &mdash; A chest X-ray can be normal if your child has a small VSD. It can show changes to the heart if there is a medium or large VSD.",
"       </li>",
"       <li>",
"        An echocardiogram &ndash; This test uses sound waves to create a picture of the heart as it beats. It can help the doctor make sure VSD is the cause of symptoms. It can also show how big the VSD is and exactly where it is in the heart. &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      These tests can also show if a child has other heart problems and what they are.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12130591\">",
"      <span class=\"h1\">",
"       How is ventricular septal defect treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment is different for each person. It depends on how big the VSD is and if it causes symptoms.",
"     </p>",
"     <p>",
"      Small VSDs often close on their own without causing symptoms. Or they might stay open, but never cause health problems.",
"     </p>",
"     <p>",
"      People who have a small VSD might not need any specific treatment unless the VSD causes problems. They can have: &nbsp;",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Regular checkups &ndash; If your baby has a small VSD, he or she might only need regular checkups. Some people have a small VSD for life that does not cause symptoms. They need regular checkups to make sure the heart stays healthy.",
"       </li>",
"       <li>",
"        Tests to check the heart &ndash; These tests can also show doctors if the heart is staying healthy.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Medium or large VSDs usually cause symptoms. People with this type of VSD need regular checkups to make sure the heart is healthy and to look for any changes. They might also need treatment. &nbsp;",
"     </p>",
"     <p>",
"      Treatments for medium or large VSDs can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Medicines to help the heart",
"       </li>",
"       <li>",
"        Making sure a child gets good nutrition - A baby with a medium or large VSD might need formula that has extra nutrition. This can help the baby gain weight and grow normally.",
"       </li>",
"       <li>",
"        Treatment to close the VSD - If a medium or large VSD does not close or get smaller by the time a baby is 6 months old, doctors can close it with:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Surgery to patch the hole &ndash; This is the most common treatment to close a VSD.",
"       </li>",
"       <li>",
"        A procedure called &ldquo;transcatheter closure&rdquo; &ndash; Doctors can do this when surgery is difficult or does not work. In this treatment, a doctor places a thin tube into a blood vessel in an arm or leg. Then, he or she moves the tube through the blood vessel to the heart. When the tube gets to the hole in the heart, the doctor uses the tube to put in a small device that closes the hole.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12130606\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/42/36514?source=see_link\">",
"       Patient information: Heart murmurs (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/51/25395?source=see_link\">",
"       Patient information: ECG and stress test (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?4/26/4514?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83036 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-194.187.108.93-69C8FD1B77-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4514=[""].join("\n");
var outline_f4_26_4514=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12130529\">",
"      What is ventricular septal defect?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12130544\">",
"      What are the symptoms of ventricular septal defect?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12130559\">",
"      Should my child see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12130574\">",
"      Will my child need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12130591\">",
"      How is ventricular septal defect treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12130606\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83036\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/60/12224\">",
"      Atrial and ventricular septal defects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/51/25395?source=related_link\">",
"      Patient information: ECG and stress test (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/42/36514?source=related_link\">",
"      Patient information: Heart murmurs (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_26_4515="Ultrasound of abnormal fetal femur";
var content_f4_26_4515=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F54680&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F54680&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ultrasound images of abnormal fetal femurs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 312px; height: 453px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Mild shortening with bowing of the femur in a 20.2 week fetus with the diagnosis of asphyxiating thoracic dystrophy.",
"    <br>",
"     (B) Severe micromelia (entire limb shortening) of the lower extremity in a fetus at 24 weeks with the diagnosis of thanatophoric dysplasia type 2. Note surrounding thickened redundant soft tissues, which have grown relatively faster than the short long bones.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4515=[""].join("\n");
var outline_f4_26_4515=null;
var title_f4_26_4516="Multiple vitamins (prenatal): Drug information";
var content_f4_26_4516=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Multiple vitamins (prenatal): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?16/53/17236?source=see_link\">",
"    see \"Multiple vitamins (prenatal): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708851\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F234684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      A-Free Prenatal [OTC];",
"     </li>",
"     <li>",
"      CitraNatal&reg; Harmony&trade;;",
"     </li>",
"     <li>",
"      CitraNatal&trade; 90 DHA;",
"     </li>",
"     <li>",
"      CitraNatal&trade; Assure;",
"     </li>",
"     <li>",
"      CitraNatal&trade; B-Calm;",
"     </li>",
"     <li>",
"      CitraNatal&trade; DHA;",
"     </li>",
"     <li>",
"      CitraNatal&trade; Rx;",
"     </li>",
"     <li>",
"      Concept DHA&trade;;",
"     </li>",
"     <li>",
"      Concept OB&trade;;",
"     </li>",
"     <li>",
"      Duet&reg;;",
"     </li>",
"     <li>",
"      Duet&reg; Balanced DHA",
"      <sup>",
"       ec",
"      </sup>",
"     </li>",
"     <li>",
"      Femecal OB;",
"     </li>",
"     <li>",
"      Folcaps&trade; Care One;",
"     </li>",
"     <li>",
"      Foltabs&trade; Prenatal;",
"     </li>",
"     <li>",
"      Foltabs&trade; Prenatal Plus DHA;",
"     </li>",
"     <li>",
"      Gesticare&reg; DHA;",
"     </li>",
"     <li>",
"      KPN Prenatal [OTC];",
"     </li>",
"     <li>",
"      Mini-Prenatal [OTC];",
"     </li>",
"     <li>",
"      Multi-Nate 30;",
"     </li>",
"     <li>",
"      NataFort&reg; [OTC];",
"     </li>",
"     <li>",
"      N&eacute;evo&reg;;",
"     </li>",
"     <li>",
"      N&eacute;evo&reg; DHA;",
"     </li>",
"     <li>",
"      One A Day&reg; Women&rsquo;s Prenatal [OTC];",
"     </li>",
"     <li>",
"      OptiNate&reg;;",
"     </li>",
"     <li>",
"      Paire OB&trade; Plus DHA;",
"     </li>",
"     <li>",
"      PreCare&reg;;",
"     </li>",
"     <li>",
"      PreferaOB&reg;;",
"     </li>",
"     <li>",
"      PreferaOB&reg; + DHA;",
"     </li>",
"     <li>",
"      PreferaOB&reg; One&trade;;",
"     </li>",
"     <li>",
"      Prenatabs FA;",
"     </li>",
"     <li>",
"      Prenatal One Daily [OTC];",
"     </li>",
"     <li>",
"      Prenatal Rx 1;",
"     </li>",
"     <li>",
"      Prenatal With Beta Carotene [OTC];",
"     </li>",
"     <li>",
"      Prenate DHA&trade;;",
"     </li>",
"     <li>",
"      Prenate Elite&reg;;",
"     </li>",
"     <li>",
"      Prenate Essential&trade;;",
"     </li>",
"     <li>",
"      PreNexa&reg; Premier;",
"     </li>",
"     <li>",
"      PrimaCare&reg; One;",
"     </li>",
"     <li>",
"      Select-OB&trade;;",
"     </li>",
"     <li>",
"      Stuart Prenatal&reg; [OTC];",
"     </li>",
"     <li>",
"      Tandem&reg; DHA;",
"     </li>",
"     <li>",
"      Tandem&reg; OB;",
"     </li>",
"     <li>",
"      TriCare&reg; Prenatal;",
"     </li>",
"     <li>",
"      TriCare&reg; Prenatal DHA One&reg;;",
"     </li>",
"     <li>",
"      Vinacal&trade;;",
"     </li>",
"     <li>",
"      Vinate&reg; Care;",
"     </li>",
"     <li>",
"      Vitafol&reg;-OB [OTC];",
"     </li>",
"     <li>",
"      Vitafol&reg;-OB+DHA [OTC];",
"     </li>",
"     <li>",
"      Vitafol&reg;-PN;",
"     </li>",
"     <li>",
"      VitaPhil + DHA",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F234692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vitamin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F234685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Dietary supplement:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, tablet: One daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder: 4 teaspoonfuls/day; given once daily or in divided doses; mix 1 teaspoonful in 1 ounce of water",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F234686\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F234674\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Content varies depending on product used. For more detailed information on ingredients in these and other multivitamins, please refer to",
"     <b>",
"      Multivitamin Product",
"     </b>",
"     comparison table.",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F234665\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F234677\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May administer with food to decrease stomach upset.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F234675\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Nutritional supplement for use prior to conception, during pregnancy, and postnatal (in lactating and nonlactating women)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F234698\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       PreCare&reg; may be confused with Precose&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F234690\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, constipation, dark stools, diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F234679\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to any component of the formulation; pre-existing hypervitaminosis",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F234668\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Iron toxicity:",
"     <b>",
"      [U.S. Boxed Warning]: Severe iron toxicity may occur in overdose, particularly when ingested by children; iron is a leading cause of fatal poisoning in children; store out of children's reach and in child-resistant containers.",
"     </b>",
"     Adult preparations may contain amounts of iron which should not be used in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hemochromatosis/hemosiderosis: Iron supplementation should not be used with hemochromatosis and hemosiderosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with severe hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Kidney stones: Use with caution in patients with kidney stones; due to calcium content.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with severe renal impairment.",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F234683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: Iron absorption is inhibited by eggs and milk.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14191344\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual vitamin monographs for requirements during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14191345\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Refer to individual vitamin monographs for requirements while breast-feeding.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F234681\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken with food to decrease stomach upset. Some products may contain phenylalanine.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16324107\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (CitraNatal Harmony Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     29-1-265 mg (30): $79.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Natelle ONE Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     28-1-250 mg (30): $136.63",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Nexa Plus Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     29-1.25-350 mg (30): $112.92",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Nexa Select Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     29-1.25-337.5 mg (30): $123.08",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (OB Complete Petite Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     35-5-1-200 mg (30): $106.20",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (PreferaOB One Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     22-6-1-200 mg (30): $99.53",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Prenatal-U Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     106.5-1 mg (100): $34.70",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Prenate Mini Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     29-0.6-0.4-350 mg (30): $111.49",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Tandem OB Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     162-115.2-1 mg (90): $52.35",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Taron-Prex Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30-1.2-265 mg (30): $51.28",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (VemaVite-PRx 2 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     27-1.25-300 mg (30): $56.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Vinate DHA Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     27-1.53 mg (30): $77.73",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Vitafol-Plus Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     27-1-200 mg (30): $62.21",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Atabex Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     18-0.8 mg (30): $13.42",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (NataChew Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     28-1 mg (90): $300.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Prenate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.6-0.4 mg (30): $110.65",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (VitaMedMD RediChew Rx Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.6-0.4 mg (30): $95.96",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Viva CT Prenatal Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     28-1 mg (30): $83.43",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Misc",
"     </b>",
"     (Prefera OB + DHA Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     28-6-1 &amp; 203 mg (60): $74.59",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (B-Nexa Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.22 mg (60): $112.92",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Clinical Nutrients Prenatal Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7.5-0.2 mg (120): $18.60",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (NataFort Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     60-1 mg (90): $77.76",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Nestabs Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     32-1 mg (90): $125.88",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Prefera OB Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     28-6-1 mg (90): $297.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Prenatabs Rx Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     29-1 mg (90): $30.77",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Prenatal Plus DHA Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7-0.4-100 mg (90): $18.26",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Right Step Prenatal Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     27-0.8 mg (100): $16.59",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Stuart Prenatal Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     28-0.8 mg (100): $24.61",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10317 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-C9EBEEE8B0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4516=[""].join("\n");
var outline_f4_26_4516=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708851\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234684\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234692\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234685\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234686\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234674\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234665\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234677\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234675\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234698\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234690\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234679\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234668\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234683\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14191344\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14191345\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234681\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16324107\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10317\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10317|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?16/53/17236?source=related_link\">",
"      Multiple vitamins (prenatal): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_26_4517="Loxapine: Patient drug information";
var content_f4_26_4517=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Loxapine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/2/27687?source=see_link\">",
"     see \"Loxapine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F190500\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Loxitane&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F190501\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Loxapine&reg;;",
"     </li>",
"     <li>",
"      Dom-Loxapine;",
"     </li>",
"     <li>",
"      Loxapac;",
"     </li>",
"     <li>",
"      Nu-Loxapine;",
"     </li>",
"     <li>",
"      PHL-Loxapine;",
"     </li>",
"     <li>",
"      Xylac&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10031355\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700570",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10031357\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692053",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat schizophrenia. It may take 6 weeks to see the full effect.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10031356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702420",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to loxapine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10031361\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697224",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma or cataracts, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697320",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have Parkinson's disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10031362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10031364\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10031359\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10031360\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10031365\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10031366\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10824 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.181.191-9843F0D5B8-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4517=[""].join("\n");
var outline_f4_26_4517=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190500\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190501\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031355\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031357\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031356\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031361\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031362\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031364\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031359\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031360\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031365\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031366\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?27/2/27687?source=related_link\">",
"      Loxapine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_26_4518="Approach anogenital condyloma";
var content_f4_26_4518=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F68884&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F68884&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 634px\">",
"   <div class=\"ttl\">",
"    Approach to anogenital condyloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 614px; height: 794px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Patients with HIV infection may have an increased risk of anal cancer.",
"     <br>",
"      &bull; Noting morphology of lesion is helpful for follow-up since patients may develop similar lesionsand growth patterns with recurrence.",
"      <br>",
"       &Delta; Compliance is important along with the ability to identify and treat all warts.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     From Sexually transmitted diseases treatment guidelines. MMWR 2006: 55:RR-11.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4518=[""].join("\n");
var outline_f4_26_4518=null;
var title_f4_26_4519="Intestinal tapeworms";
var content_f4_26_4519=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Intestinal tapeworms",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/26/4519/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/26/4519/contributors\">",
"     Karin Leder, MBBS, FRACP, PhD, MPH, DTMH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/26/4519/contributors\">",
"     Peter F Weller, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/26/4519/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/26/4519/contributors\">",
"     Edward T Ryan, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/26/4519/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/26/4519/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/26/4519/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tapeworms (cestodes) are flat, hermaphroditic worms that can live as parasites in the human gastrointestinal tract. Some of these organisms are primarily human pathogens, while others have animals as their natural hosts but can also cause human infection.",
"   </p>",
"   <p>",
"    Taeniasis, Diphyllobothriasis, Hymenolepiasis, and Dipylidiasis will be reviewed here. Ingestion of the eggs of Taenia solium causes cysticercosis, a tapeworm infection which is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15413?source=see_link\">",
"     \"Epidemiology, transmission and prevention of cysticercosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28232?source=see_link\">",
"     \"Clinical manifestations and diagnosis of cysticercosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/28/17865?source=see_link\">",
"     \"Treatment of cysticercosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30381309\">",
"    <span class=\"h1\">",
"     MORPHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adult tapeworms consist of a head, neck, and segmented body. The head (also known as a scolex), is equipped with suckers, hooks, or grooves (depending upon the species); the worm uses these to attach itself to the intestine of the host.",
"   </p>",
"   <p>",
"    Each segment (known as a proglottid), has a complete set of reproductive organs. Depending on the species, the adult worm may have hundreds or thousands of proglottids. In some species (such as Taenia), the distal segments can separate from the rest of the body and the proglottids (or the eggs they contain) are passed in the stool. In other species (such as Hymenolepis), proglottids degenerate within the host so only eggs are found in the stool.",
"   </p>",
"   <p>",
"    Tapeworms are covered with a tegument through which they absorb nutrients and secrete waste. Different species of tapeworms can be differentiated by morphologic characteristics of the scolex, proglottids, and eggs [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30381316\">",
"    <span class=\"h1\">",
"     INTESTINAL TAPEWORMS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Taeniasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two main species of Taenia for which humans are the only definitive hosts. These are Taenia saginata, the beef tapeworm, and Taenia solium, the pork tapeworm. T. saginata occurs worldwide, but is most common in areas where consumption of undercooked beef is customary, such as Europe and parts of Asia. The third species, T. asiatica, is found among pigs in Taiwan, Korea, China, Vietnam, and Indonesia [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Concurrent infections with more than one Taenia species have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Issues related to T. saginata are discussed here. The epidemiology, transmission, clinical manifestations, diagnosis, treatment, and prevention of cysticercosis due to T. solium are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15413?source=see_link\">",
"     \"Epidemiology, transmission and prevention of cysticercosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28232?source=see_link\">",
"     \"Clinical manifestations and diagnosis of cysticercosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/28/17865?source=see_link\">",
"     \"Treatment of cysticercosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Life cycle",
"    </span>",
"    &nbsp;&mdash;&nbsp;Humans are the only definitive hosts for T. saginata, T. solium, and T. asiatica (",
"    <a class=\"graphic graphic_figure graphicRef64879 \" href=\"UTD.htm?43/24/44423\">",
"     figure 1",
"    </a>",
"    ). Eggs or gravid proglottids are passed in human stool; eggs can survive for days to months in the environment. Cattle (T. saginata) and pigs (T. solium and T. asiatica) become infected by ingesting vegetation contaminated with eggs or gravid proglottids. In the animal&rsquo;s intestine, the oncospheres hatch, invade the intestinal wall, and migrate hematogenously to striated muscles, where they develop into cysticerci.&nbsp;Cysticercus contain protoscolices; they usually measure 5 by 10 mm can survive for several years in the animal.&nbsp;",
"   </p>",
"   <p>",
"    Humans become infected by ingesting raw or undercooked infected meat containing cysticerci.&nbsp;In the human intestine, protoscolices are released from the cysts and attach to the intestinal wall via suckers and hooks. Each protoscolex can become the head of an adult tapeworm, which develops by forming proglottids that arise from the caudal end of the scolex; this occurs over about two months and the adult tapeworm can survive for years in the small intestine.&nbsp;Most human infections are with only one or a few adult tapeworms.",
"   </p>",
"   <p>",
"    The length of adult worm is usually &le;5 m for T. saginata (however it may reach up to 25 m) and 2 to 7 m for T. solium.&nbsp;The adult worms produce proglottids which mature, become gravid, detach from the tapeworm, and are passed in the stool (approximately six per day).&nbsp;T. saginata adult worms usually have 1000 to 2000 proglottids, while T. solium adult worms have an average of 1000 proglottids.&nbsp;The eggs in the gravid proglottids are released after the proglottids are passed in the stool. T. saginata may produce up to 100,000 eggs per proglottid and T. solium may produce 50,000 eggs per proglottid.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most human carriers of adult tapeworms are asymptomatic. Intermittently patients may pass proglottids in the stool (T. solium) or spontaneously (T. saginata), or may notice segments their stool or sense the movement of proglottids through the anus. There may be associated symptoms including nausea, anorexia, or epigastric pain. Anxiety, headache, dizziness, and urticaria can also occur. A peripheral eosinophilia (up 15 percent) may be observed.",
"   </p>",
"   <p>",
"    Occasionally segments can enter the appendix, common bile duct, or pancreatic duct and cause obstruction. Rarely, proglottids can be aspirated or regurgitated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis is generally established by identifying eggs or proglottids in the stool. The eggs of Taenia species are morphologically indistinguishable (",
"    <a class=\"graphic graphic_picture graphicRef59510 \" href=\"UTD.htm?31/28/32201\">",
"     picture 1",
"    </a>",
"    ); they are round with a double-walled, radially striated membrane and measure 30 to 40 micrometers. T. saginata eggs have an acid-fast shell; T. solium eggs are not acid fast.",
"   </p>",
"   <p>",
"    The proglottids and scolices of T. solium and T. saginata are morphologically distinguishable and can be used to establish a species diagnosis (",
"    <a class=\"graphic graphic_picture graphicRef78855 \" href=\"UTD.htm?2/30/2528\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef62252 \" href=\"UTD.htm?33/5/33881\">",
"     picture 3",
"    </a>",
"    ). The T. saginata proglottids have 12 or more primary uterine branches; T. solium proglottids &le;10. These branches can be seen on direct examination or by injecting India ink into the segment via its lateral genital opening.",
"   </p>",
"   <p>",
"    The scolex usually remains in the intestine when proglottids are passed; it is rare for the entire worm to be eliminated spontaneously. Following antiparasitic therapy, however, the scolex of a fully evacuated worm may be identified in the stool. T. saginata has a scolex with four lateral suckers and no hooks (&ldquo;unarmed&rdquo;). T. solium has a scolex with a well developed rostellum (crown) that has four suckers and a double row of hooks (&ldquo;armed&rdquo;).",
"   </p>",
"   <p>",
"    The sensitivity of stool examination is limited since elimination of eggs and proglottids is intermittent. To increase the diagnostic yield, repeat specimens should be examined and concentration techniques can be used. In addition, T. Saginata eggs may be deposited on perianal areas and be detected by anal swabs using adhesive tape.",
"   </p>",
"   <p>",
"    Laboratory workers must exercise caution when performing stool examinations; T. solium eggs are infectious if ingested [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28232?source=see_link\">",
"     \"Clinical manifestations and diagnosis of cysticercosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In order to improve diagnostic sensitivity, immunologic and molecular methods have been developed. The two methods which show most promise for potential commercial use are an enzyme linked immunosorbent assay (ELISA) for the detection of T. solium antigens in fecal samples and DNA hybridization techniques for the detection of eggs in stools [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/8-12\">",
"     8-12",
"    </a>",
"    ]. A dipstick dot ELISA for detection of Taenia-specific coproantigens (soluble stool antigens) has been developed for use in field studies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, this test was compared with microscopy and with examination for evacuated worms following therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/13\">",
"       13",
"      </a>",
"      ]. The use of the coproantigen test significantly increased the number of cases diagnosed with a sensitivity and specificity of approximately 75 and 99.9 percent, respectively.",
"     </li>",
"     <li>",
"      Another report employed a sandwich ELISA to detect coproantigens in the stool of infected humans and found the sensitivity of the assay to be 85 percent, compared with only 62 percent for microscopy [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/14\">",
"       14",
"      </a>",
"      ]. The specificity was 95 percent. The assay became negative 9 to 17 days after successful treatment, suggesting it could also be used for follow-up.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Diphyllobothriasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diphyllobothriasis (fish tapeworm) is the largest human tapeworm. The most common species worldwide is D. latum, which is observed predominantly in northern Europe and Japan but has also been observed in other countries. Freshwater fish infected with Diphyllobothrium larvae may be transported to and consumed in areas where active transmission does not occur. For example, cases of D. latum infection associated with consumption of imported fish have been reported in Brazil [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/15\">",
"     15",
"    </a>",
"    ]. Other species include D. pacificum (Peru), D. dentriticum (especially Alaska), and D. ursi (Alaska and Canada).",
"   </p>",
"   <p>",
"    D. latum infection can be transmitted by consumption of a variety of freshwater fish. Individuals who eat various forms of raw fish, such as sushi, sashimi, and ceviche, are at risk of infection.",
"   </p>",
"   <p>",
"    Humans are the main definitive host for D. latum and the most important reservoir of infection. Some other Diphyllobothrium species primarily infect birds or mammals and are less common causes of human infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Life cycle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The adult parasites live in the human intestinal tract, and eggs and proglottids are passed in the stool (",
"    <a class=\"graphic graphic_figure graphicRef72572 \" href=\"UTD.htm?39/2/39976\">",
"     figure 2",
"    </a>",
"    ). Under appropriate conditions, the eggs embryonate in water (after approximately 18 to 20 days); coracidia hatch from eggs and are ingested by small crustaceans (the first intermediate host).",
"   </p>",
"   <p>",
"    The coracidia develop into procercoid larvae in the body cavity of the infected crustacean, which is then ingested by small freshwater fish (the second intermediate host), typically minnows. The procercoid larvae are released from the crustacean and migrate into the fish flesh where they develop into a plerocercoid larvae (sparganum).&nbsp;The sparganum are the infective stage for humans. Since humans do not generally eat undercooked minnows or other small freshwater fish, these do not represent an important source of infection. These small freshwater fish are eaten by larger predator species (later intermediate host), such as trout, perch or pike.",
"   </p>",
"   <p>",
"    The sparganum can migrate from the small fish to the musculature of the larger predator fish; humans and other mammals can acquire infection by eating these predator fish raw or undercooked. After human ingestion of the infected fish, the sparganum develop into mature adult tapeworms which reside in the small intestine.&nbsp;The D. latum adult worms attach to the intestinal mucosa via the two bilateral groves of their scolex.&nbsp;The adults can grow up to 12 m in length, with 3000 to 4000 proglottids. Immature eggs are released from the proglottids (up to one million eggs per day per worm) and are intermittently passed in the stool beginning five to six weeks after infection. The adult tapeworm survives for approximately 10 years in the human intestine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most individuals with diphyllobothriasis are asymptomatic. Occasionally a proglottid can be passed in the stool or regurgitated, but this occurs less commonly than with Taenia species. Nonspecific symptoms that have been attributed to infection include fatigue, diarrhea, numbness, dizziness, and allergic symptoms. Occasionally mechanical obstruction of the intestine can occur if several worms become entangled. A peripheral eosinophilia (5 to 10 percent) may be observed in some patients.",
"   </p>",
"   <p>",
"    The classical manifestation of infection with D. latum is megaloblastic anemia due to vitamin B12 deficiency. D. latum has a unique affinity for vitamin B12 and therefore competes with the host for absorption. Vitamin B12 deficiency is more likely to develop if the host had marginal levels before acquiring the infection. It has been reported that approximately 40 percent of infected individuals have low vitamin B12 levels, but only about 2 percent actually develop anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/1\">",
"     1",
"    </a>",
"    ]. In the setting of severe vitamin B12 deficiency is severe, pancytopenia, glossitis, dyspnea, and neurologic abnormalities (subacute combined spinal and peripheral nerve degeneration) can develop. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=see_link\">",
"     \"Etiology and clinical manifestations of vitamin B12 and folate deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Megaloblastic anemia and vitamin B12 deficiency can be a clue to the diagnosis of diphyllobothriasis.",
"   </p>",
"   <p>",
"    The diagnosis is generally established by identifying eggs or proglottids in the stool (",
"    <a class=\"graphic graphic_picture graphicRef50301 \" href=\"UTD.htm?37/63/38896\">",
"     picture 4",
"    </a>",
"    ). The eggs of Diphyllobothrium species have an operculum, or lid-like opening, which is commonly seen in trematode eggs but is not seen with eggs of other cestodes (",
"    <a class=\"graphic graphic_picture graphicRef59791 \" href=\"UTD.htm?43/41/44702\">",
"     picture 5",
"    </a>",
"    ). The eggs measure 40 by 60 mcm and have a small knob on the end opposite the operculum. Concentration methods are not necessary for diagnosis in most cases, since there are typically large numbers of eggs present in the stool.",
"   </p>",
"   <p>",
"    The scolex of the adult is spoon-shaped and has characteristic ventral sucking grooves (known as &ldquo;bothria&rdquo;) with which the worm attaches to the intestinal mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/16\">",
"     16",
"    </a>",
"    ]. The proglottids can be differentiated from Taenia proglottids because their width is greater than length, and there is a characteristic egg-filled uterus that appears as a dark rosette in the center of mature proglottids (",
"    <a class=\"graphic graphic_picture graphicRef50903 \" href=\"UTD.htm?38/13/39129\">",
"     picture 6",
"    </a>",
"    ). It is generally difficult to distinguish among the species of Diphyllobothrium based on morphology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Hymenolepiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hymenolepis nana (dwarf tapeworm) differs from most other tapeworms since it can complete its entire life cycle in a single host (",
"    <a class=\"graphic graphic_figure graphicRef53545 \" href=\"UTD.htm?17/39/18040\">",
"     figure 3",
"    </a>",
"    ). Its name derives from the fact that the adult parasite is much smaller than most other cestodes, measuring only 30 to 40 mm by 1 mm. H. nana is the most common human tapeworm infection worldwide. Transmission is associated with poor sanitation and hygiene, and can occur between humans in the absence of an intermediate host. It is especially prevalent in warm countries such as Egypt, Sudan, Thailand, India, and Latin American countries. It has been reported to affect 4 percent of school children in rural southeastern United States [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3887034\">",
"    <span class=\"h3\">",
"     Life cycle",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eggs of H. nana are immediately infective when passed in the stool and cannot survive more than 10 days in the external environment.&nbsp;Humans may ingest these eggs via contaminated food or water; thereafter the oncospheres within the eggs are released and penetrate the intestinal villus where they develop into cysticercoid larvae. After five to six days these develop into adult tapeworms which attach to the ileum via the scolex, which consists of four suckers and a retractable rostellum with a single circle of 20 to 30 hooks. Production of new eggs begins approximately 20 to 30 days after initial infection; eggs are passed in the stool when released from proglottids or when proglottids disintegrate in the small intestine.&nbsp;",
"   </p>",
"   <p>",
"    Internal autoinfection is also possible; eggs can release their oncospheres within the human intestine, continuing the infective cycle without passage through the external environment.&nbsp;The life span of adult worms is four to six weeks, but internal autoinfection allows the infection to persist for years.",
"   </p>",
"   <p>",
"    Alternatively, the eggs passed in the stool may be ingested by an arthropod intermediate host (various species of beetles and fleas may serve as intermediate hosts). Cysticercoid larvae develop within the insect, which are then ingested by humans or rodents and develop into adult worms in the small intestine. Humans can become infected by ingesting the infected insects accidentally, often in contaminated grain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection with H. nana is most common in children, since they are more prone to breaches in fecal-oral hygiene. Most infections are asymptomatic, but symptoms become more common as the parasite burden increases. Heavy infections with &gt;1000 worms can occur and are often associated with crampy abdominal pain, diarrhea, anorexia, and pruritus ani. Dizziness, irritability, sleep disturbance, and seizures have also been described. A peripheral blood eosinophilia of 5 to 10 percent may be observed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis is generally established by identifying eggs or proglottids in the stool (",
"    <a class=\"graphic graphic_picture graphicRef72451 \" href=\"UTD.htm?42/59/43954\">",
"     picture 7",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef62695 \" href=\"UTD.htm?36/24/37256\">",
"     picture 8",
"    </a>",
"    ). Eggs are 30 to 50 mcm in diameter. They contain an oncosphere and are covered with a thin hyaline outer membrane and a thick inner membrane; four to eight hairlike filaments arise from the even thicker polar ends of the membrane. Proglottids disintegrate in the intestine and are not found in the feces. The sensitivity of stool microscopy can be increased by using concentration techniques.",
"   </p>",
"   <p>",
"    Diagnosis of hymenolepiasis should prompt family screening or empiric treatment, given the potential for person-to-person spread.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Other tapeworms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hymenolepis diminuta is a species related to H. nana that is primarily a parasite of domestic rats (",
"    <a class=\"graphic graphic_figure graphicRef74543 \" href=\"UTD.htm?2/19/2359\">",
"     figure 4",
"    </a>",
"    ). Humans can be infected as accidental hosts by swallowing infected insects, such as grain beetles or mealworms (intermediate hosts), usually in flour or cereals. Infection occurs mainly in areas with heavy rodent infestation. The worms and the eggs are morphologically different from H. nana, but similar symptoms can develop.",
"   </p>",
"   <p>",
"    The dog tapeworm, Dipylidium caninum, commonly infects domestic cats and dogs and may also accidentally infect humans (",
"    <a class=\"graphic graphic_figure graphicRef53612 \" href=\"UTD.htm?9/2/9257\">",
"     figure 5",
"    </a>",
"    ). Fleas usually serve as the intermediate hosts and contain cysticercoids. If an animal or human (usually a child) ingests cysticercoids, an adult tapeworm can develop in the intestine. Infection is usually asymptomatic; abdominal pain, diarrhea, pruritus ani, and urticaria can develop. Parents may notice the passage of proglottids in their children&rsquo;s stool. The adult tapeworm is 15 to 20 cm in length.",
"   </p>",
"   <p>",
"    Some cestodes only infect humans in the larval stage, including sparganosis due to Spirometra species and coenuriasis due to Taenia multiceps.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/16/25860?source=see_link\">",
"     Praziquantel",
"    </a>",
"    is the treatment of choice for all of the tapeworm infections discussed above [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/18\">",
"     18",
"    </a>",
"    ]. Dosing depends upon the species [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/19\">",
"     19",
"    </a>",
"    ]. Dosing for taeniasis and diphyllobothriasis is 5 to 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    orally (single dose), although excellent efficacy against T. saginata infections has been reported at doses as low as 2.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/20\">",
"     20",
"    </a>",
"    ]. Dosing for hymenolepiasis is 25",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    orally (single dose), followed by repeat dose 10 days later.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/16/25860?source=see_link\">",
"     Praziquantel",
"    </a>",
"    is a synthetic heterocyclic isoquinolone-pyrazine derivative that induces ultrastructural changes in the teguments of parasites, resulting in increased permeability to calcium ions. Calcium ions accumulate in the parasite cytosol, leading to muscular contractions and ultimate paralysis of adult worms [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/21\">",
"     21",
"    </a>",
"    ]. By damaging the tegument membrane, praziquantel also exposes parasite antigens to host immune responses [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/22\">",
"     22",
"    </a>",
"    ]. These effects lead to dislodgement of worms from their intestinal sites and subsequent expulsion by peristalsis.",
"   </p>",
"   <p>",
"    Niclosamide is an acceptable alternative treatment for tapeworms if",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/16/25860?source=see_link\">",
"     praziquantel",
"    </a>",
"    is not available. Niclosamide comes in 500 mg tablets that need to be chewed; it is not available in the United States. Dosing consists of is four tablets (500 mg) in a single dose (2 g) for adults, two tablets (1 gram) for children 11 to 34 kg, and three tablets (1.5 grams) for children &gt;34 kg.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5508?source=see_link\">",
"     Nitazoxanide",
"    </a>",
"    has been used to treat hymenolepiasis with 75 to 85 percent efficacy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Dosing consists of 500 mg twice daily for three days (for patients &gt;11 years of age); 200 mg twice daily for three days (for patients 4 to 11 years of age); and 100 mg twice daily for three days (for patients one to three years of age) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4519/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For successful treatment, the scolex must be destroyed and eliminated; a residual scolex can result in regrowth of the entire tapeworm. After treatment, the proximal parts of the tapeworms disintegrate, and gravid proglottids can release eggs as they are being destroyed. Because",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/16/25860?source=see_link\">",
"     praziquantel",
"    </a>",
"    kills adult worms but not eggs, precautions should be taken to prevent autoinfection, laboratory-acquired infection, or dissemination to others. With large tapeworms, such as Taenia and diphyllobothrium species, intact or disintegrating segments and eggs may be passed for several days. Following therapy, stools should be rechecked for eggs at one month (Hymenolepiasis or Diphyllobothriasis) or three months (Taeniasis) to document cure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12131100\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tapeworms (cestodes) are flat, hermaphroditic worms that can live as parasites in the human gastrointestinal tract. Some of these organisms are primarily human pathogens, while others have animals as their natural hosts, but can also cause human infection. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      T. saginata occurs worldwide but is most common in areas where consumption of undercooked beef is customary, such as Europe and parts of Asia (",
"      <a class=\"graphic graphic_figure graphicRef64879 \" href=\"UTD.htm?43/24/44423\">",
"       figure 1",
"      </a>",
"      ). Most human carriers of adult tapeworms are asymptomatic; there may be associated symptoms, including nausea, anorexia, or epigastric pain, and a peripheral eosinophilia may be observed. The diagnosis is generally established by identifying eggs or proglottids in the stool (",
"      <a class=\"graphic graphic_picture graphicRef59510 \" href=\"UTD.htm?31/28/32201\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Taeniasis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      D. latum is the most common species of fish tapeworm worldwide; it is observed predominantly in northern Europe and Japan but has also been observed in other countries. D. latum infection can be transmitted by consumption of a variety of raw freshwater fish (",
"      <a class=\"graphic graphic_figure graphicRef72572 \" href=\"UTD.htm?39/2/39976\">",
"       figure 2",
"      </a>",
"      ). Megaloblastic anemia due to vitamin B12 deficiency is a classical manifestation of infection. The diagnosis is generally established by identifying eggs or proglottids in the stool (",
"      <a class=\"graphic graphic_picture graphicRef50301 \" href=\"UTD.htm?37/63/38896\">",
"       picture 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diphyllobothriasis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      H. nana can be transmitted between humans in the absence of an intermediate host, or via an alternative life cycle including rodents and arthropods (",
"      <a class=\"graphic graphic_figure graphicRef74543 \" href=\"UTD.htm?2/19/2359\">",
"       figure 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef53545 \" href=\"UTD.htm?17/39/18040\">",
"       figure 3",
"      </a>",
"      ). It is associated with poor sanitation and is prevalent in warm regions including Egypt, Sudan, Thailand, India, and Latin American countries. Infection is most common in children. Most infections are asymptomatic, but heavy infection may be associated with crampy abdominal pain, diarrhea, anorexia, and pruritus ani. The diagnosis is generally established by identifying eggs or proglottids in the stool (",
"      <a class=\"graphic graphic_picture graphicRef62695 \" href=\"UTD.htm?36/24/37256\">",
"       picture 8",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef72451 \" href=\"UTD.htm?42/59/43954\">",
"       picture 7",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Hymenolepiasis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/16/25860?source=see_link\">",
"       praziquantel",
"      </a>",
"      for treatment of infection due to T. saginata, D. latum, and H. nana (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Dosing depends on the species. Niclosamide is an acceptable alternative treatment if praziquantel is not available. Following therapy, stools should be rechecked for eggs to document cure. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/1\">",
"      Schantz PM. Tapeworms (cestodiasis). Gastroenterol Clin North Am 1996; 25:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/2\">",
"      Flisser A, Viniegra AE, Aguilar-Vega L, et al. Portrait of human tapeworms. J Parasitol 2004; 90:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/3\">",
"      Eom KS. What is Asian Taenia? Parasitol Int 2006; 55 Suppl:S137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/4\">",
"      Hoberg EP. Phylogeny of Taenia: Species definitions and origins of human parasites. Parasitol Int 2006; 55 Suppl:S23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/5\">",
"      Botero D, Tanowitz HB, Weiss LM, Wittner M. Taeniasis and cysticercosis. Infect Dis Clin North Am 1993; 7:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/6\">",
"      Schantz PM, Moore AC, Mu&ntilde;oz JL, et al. Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med 1992; 327:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/7\">",
"      Craig P, Ito A. Intestinal cestodes. Curr Opin Infect Dis 2007; 20:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/8\">",
"      Flisser A, Plancarte A, Correa D, et al. New approaches in the diagnosis of Taenia solium cysticercosis and taeniasis. Ann Parasitol Hum Comp 1990; 65 Suppl 1:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/9\">",
"      Allan JC, Avila G, Garcia Noval J, et al. Immunodiagnosis of taeniasis by coproantigen detection. Parasitology 1990; 101 Pt 3:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/10\">",
"      Maass M, Delgado E, Knobloch J. Detection of Taenia solium antigens in merthiolate-form preserved stool samples. Trop Med Parasitol 1991; 42:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/11\">",
"      Chapman A, Vallejo V, Mossie KG, et al. Isolation and characterization of species-specific DNA probes from Taenia solium and Taenia saginata and their use in an egg detection assay. J Clin Microbiol 1995; 33:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/12\">",
"      Allan JC, Craig PS. Coproantigens in taeniasis and echinococcosis. Parasitol Int 2006; 55 Suppl:S75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/13\">",
"      Allan JC, Mencos F, Garcia-Noval J, et al. Dipstick dot ELISA for the detection of Taenia coproantigens in humans. Parasitology 1993; 107 ( Pt 1):79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/14\">",
"      Deplazes P, Eckert J, Pawlowski ZS, et al. An enzyme-linked immunosorbent assay for diagnostic detection of Taenia saginata copro-antigens in humans. Trans R Soc Trop Med Hyg 1991; 85:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/15\">",
"      Cabello FC. Salmon aquaculture and transmission of the fish tapeworm. Emerg Infect Dis 2007; 13:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/16\">",
"      Nakaji K, Suzumura S, Nakae Y, et al. Effects in the control of edema of the papilla of Vater by epinephrine saline irrigation after endoscopic retrograde cholangiopancreatography in an endoscopy center in Japan, 2003 to 2007: exploratory retrospective analysis to evaluate the characteristics of eligible patients with a focus on serum amylase levels. Intern Med 2009; 48:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/17\">",
"      Flores EC, Plumb SC, McNeese MC. Intestinal parasitosis in an urban pediatric clinic population. Am J Dis Child 1983; 137:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/18\">",
"      Groll E. Praziquantel for cestode infections in man. Acta Trop 1980; 37:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/19\">",
"      Drugs for parasitic infections. Med Lett Drugs Ther 2010; 8:e20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/20\">",
"      Paw��owski ZS. Efficacy of low doses of praziquantel in taeniasis. Acta Trop 1990; 48:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/21\">",
"      Brindley PJ, Sher A. Immunological involvement in the efficacy of praziquantel. Exp Parasitol 1990; 71:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/22\">",
"      Frayha GJ, Smyth JD, Gobert JG, Savel J. The mechanisms of action of antiprotozoal and anthelmintic drugs in man. Gen Pharmacol 1997; 28:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/23\">",
"      Juan JO, Lopez Chegne N, Gargala G, Favennec L. Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru. Trans R Soc Trop Med Hyg 2002; 96:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4519/abstract/24\">",
"      Chero JC, Saito M, Bustos JA, et al. Hymenolepis nana infection: symptoms and response to nitazoxanide in field conditions. Trans R Soc Trop Med Hyg 2007; 101:203.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5685 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-118.195.65.248-72FD83CAD0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4519=[""].join("\n");
var outline_f4_26_4519=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12131100\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30381309\">",
"      MORPHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30381316\">",
"      INTESTINAL TAPEWORMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Taeniasis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Life cycle",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Diphyllobothriasis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Life cycle",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Hymenolepiasis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3887034\">",
"      - Life cycle",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Other tapeworms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12131100\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/5685\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5685|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/24/44423\" title=\"figure 1\">",
"      Taeniasis life cycle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/2/39976\" title=\"figure 2\">",
"      Diphyllobothriasis life cycle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/39/18040\" title=\"figure 3\">",
"      Hymenolepis nana life cycle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/19/2359\" title=\"figure 4\">",
"      Hymenolepis diminuta life cycle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/2/9257\" title=\"figure 5\">",
"      Dipylidium caninum life cycle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5685|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/28/32201\" title=\"picture 1\">",
"      Taeniasis eggs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/30/2528\" title=\"picture 2\">",
"      Taenia scolices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/5/33881\" title=\"picture 3\">",
"      Taenia proglottids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/63/38896\" title=\"picture 4\">",
"      D latum egg iodine stain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/41/44702\" title=\"picture 5\">",
"      Diphyllobothrium latum egg",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/13/39129\" title=\"picture 6\">",
"      Diphyllobothriasis proglottids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/59/43954\" title=\"picture 7\">",
"      Hymenolepiasis diminuta eggs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/24/37256\" title=\"picture 8\">",
"      Hymenolepiasis nana eggs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28232?source=related_link\">",
"      Clinical manifestations and diagnosis of cysticercosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15413?source=related_link\">",
"      Epidemiology, transmission and prevention of cysticercosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=related_link\">",
"      Etiology and clinical manifestations of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/28/17865?source=related_link\">",
"      Treatment of cysticercosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_26_4520="Renal involvement in the mitochondrial cytopathies";
var content_f4_26_4520=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Renal involvement in the mitochondrial cytopathies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/26/4520/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/26/4520/contributors\">",
"     Patrick Niaudet, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/26/4520/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/26/4520/contributors\">",
"     Tej K Mattoo, MD, DCH, FRCP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/26/4520/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/26/4520/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/26/4520/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/26/4520/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 7, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitochondrial cytopathies are a heterogeneous group of disorders characterized by genetic defects in one or more of the enzymatic complexes of the respiratory chain. These disorders impair oxidative phosphorylation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/1-3\">",
"     1-3",
"    </a>",
"    ], and were long regarded as neuromuscular diseases. However, they also cause dysfunction of the kidney and other organs because many tissues, in addition to muscle and brain, are highly dependent upon mitochondrial energy supply [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=see_link\">",
"     \"Mitochondrial myopathies: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An overview of the mitochondrial cytopathies, with an emphasis on associated kidney disorders, is presented here. A brief review of the physiology and genetics of the mitochondria is required to fully understand the various clinical manifestations of the mitochondrial cytopathies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MITOCHONDRIAL RESPIRATORY CHAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main function of the mitochondrion is the production of ATP by oxidative phosphorylation. Oxidative phosphorylation occurs in the mitochondrial inner membrane, and includes the oxidation of fuel molecules with energy transduction into ATP. During this process, reducing equivalents are transferred to oxygen via the complexes of the mitochondrial respiratory chain. The mitochondrial structure, function, and genetics are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12853?source=see_link\">",
"     \"Mitochondrial structure, function, and genetics\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     GENETICS AND DISORDERS WITH RENAL INVOLVEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in both mitochondrial and nuclear genes have been identified in patients with mitochondrial disorder and renal involvement. However, the molecular definition of the genetic mutation underlying mitochondrial respiratory chain defects is complicated by the dual genetic control of respiratory chain proteins, and by the high number of genes involved in the biogenesis and the assembly of the respiratory chain (",
"    <a class=\"graphic graphic_table graphicRef55067 \" href=\"UTD.htm?16/14/16621\">",
"     table 1",
"    </a>",
"    ). Therefore, the genetics that underlie a mitochondrial disorder with renal involvement have been identified in only a few patients and families. These will be reviewed in the following sections. Disorders with primarily extrarenal manifestations due to mutations in mitochondrial genes are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=see_link\">",
"     \"Mitochondrial myopathies: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      DNA point mutations &mdash; Point mutations in the A3243G mitochondrial DNA (mtDNA) are associated with Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-like episodes (MELAS) syndrome. Mutations of this gene result in impairment of mtDNA mitochondrial translation. A3243G mtDNA mutations have been detected in adults with diabetes mellitus and renal failure who subsequently develop characteristic signs of MELAS syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/8,9\">",
"       8,9",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Adults'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      mtDNA rearrangements &mdash; Large mtDNA rearrangements have been described in several patients with tubulopathy, chronic tubulointerstitial nephritis, or renal tubular dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/10-12\">",
"       10-12",
"      </a>",
"      ]. These deletions take away 2-to-10 kb of mtDNA and usually encompassed several coding and tRNA genes. They are often sporadic and probably occur de novo during oogenesis or in early development. The size and the location of these deletions are not related either to the clinical symptoms or to the severity of the disease.",
"     </li>",
"     <li>",
"      mtDNA depletions &mdash; Cases of lethal infantile respiratory, muscle, liver, or kidney failure have been ascribed to mtDNA depletions [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/13,14\">",
"       13,14",
"      </a>",
"      ]. In these patients, there is a paucity of mtDNA copy numbers in one or more tissues but not of nuclear DNA. As expected, these patients have multiple respiratory chain deficiencies in affected tissues, including the kidney in some patients.",
"     </li>",
"     <li>",
"      Nuclear genes &mdash; Renal disease due to mitochondrial dysfunction associated with a nuclear gene mutation is rare. Case reports of patients with kidney disease associated with a nuclear gene mutation that impairs the mitochondrial respiratory chain include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A COX10 gene mutation was identified in a child who presented with ataxia and growth failure at 18 months with continued neurologic deterioration over the next six months [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/15\">",
"       15",
"      </a>",
"      ]. Renal involvement was suggested by increased levels of urinary amino acids, indicating proximal tubulopathy.",
"     </li>",
"     <li>",
"      Mutations of the BCS1 gene that encodes a mitochondrial inner membrane protein, which chaperones the assembly of complex III of the respiratory chain, has been identified in patients from four families with a constellation of clinician findings: liver failure, lactic acidosis, hepatocellular insufficiency, tubulopathy, encephalopathy, deafness, and blindness [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL CHARACTERISTICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitochondrial diseases may present at any age [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/6\">",
"     6",
"    </a>",
"    ]. However, one-third of patients with respiratory enzyme deficiencies have initial symptoms during the first month of life.",
"   </p>",
"   <p>",
"    The two major clinical features of mitochondrial disease are [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A progressive increase in the number of affected tissues or organs over an individual's lifetime",
"     </li>",
"     <li>",
"      The almost constant involvement of the central nervous system in the later stages of the disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Extrarenal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extrarenal manifestations of mitochondrial disease include neuromuscular disorders, sensorineural hearing loss, diabetes mellitus, gastrointestinal disease, and cardiac involvement. Specific mitochondrial myopathies and their clinical features are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=see_link\">",
"     \"Mitochondrial myopathies: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Renal",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 5 percent of patients with mitochondrial disorders, renal involvement is observed that can affect the tubules, interstitium, or glomeruli [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/3,6,7,18-20\">",
"     3,6,7,18-20",
"    </a>",
"    ]. If mild tubular impairment is also considered, a significant number of patients (up to 50 percent in some series) may have kidney involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Tubular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common renal manifestation of mitochondrial disorders is the de Toni-Debr&eacute;-Fanconi syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/6\">",
"     6",
"    </a>",
"    ]. The impairment in proximal tubular reabsorption in this disorder leads to glucosuria, tubular proteinuria (including generalized amino aciduria), renal tubular acidosis, hypokalemia, and hypouricemia [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/10,18,21-30\">",
"     10,18,21-30",
"    </a>",
"    ]. Symptoms usually begin during the neonatal period or before two years of age. Sodium and water wasting can result in polyuria (reaching 2 to 3",
"    <span class=\"nowrap\">",
"     L/day),",
"    </span>",
"    polydipsia, and episodes of vomiting, unexplained fever, and acute dehydration. Growth retardation and rickets are often noted at presentation, in part because of phosphate wasting and hypophosphatemia [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Proximal renal tubular acidosis also may be observed in patients with mitochondrial disorders, including Kearns-Sayre syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. These patients may also have hypercalciuria [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/33\">",
"     33",
"    </a>",
"    ]. In one case report, hypoparathyroidism and severe hypomagnesemia secondary to tubular dysfunction was observed in a patient with Kearns-Sayre syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/34\">",
"     34",
"    </a>",
"    ]. One case reports extrarenal symptoms are present in all such patients. Patients with mitochondrial disorder may also present with signs of salt depletion and with hypokalemic metabolic alkalosis similar to findings seen in Bartter syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. Extrarenal symptoms are present in all such patients.",
"   </p>",
"   <p>",
"    Renal biopsy typically reveals severe nonspecific tubular abnormalities, including tubular dilations or obliteration by casts, dedifferentiation or atrophy. Some tubular cells show cytoplasmic vacuolization, and giant mitochondria are frequently observed.",
"   </p>",
"   <p>",
"    Proximal renal tubular acidosis also may be caused by other cytopathies, including Kearns-Sayre syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. Extrarenal symptoms are present in all such patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Glomerular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are reported cases of patients with mitochondrial dysfunction and glomerular disease. These patients most often present with steroid-resistant nephrotic syndrome, and renal biopsy reveals focal segmental glomerulosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/38-41\">",
"     38-41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rarely, mutations of the following genes that affect the CoQ pathway in the respiratory chain have been detected in patients with glomerular disease who present with steroid-resistant nephrotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/41-43\">",
"     41-43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The COQ2 gene encodes the para-hydroxybenzoate-polyprenyl-transferase enzyme of the CoQ10 pathway. Patients with this gene mutation may have severe steroid-resistant nephrotic syndrome with rapid progression to renal failure [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/41,42\">",
"       41,42",
"      </a>",
"      ]. Renal biopsy demonstrates a collapsing form of focal segmental glomerulosclerosis. Ultrastructural examination of tissue from the renal biopsy reveals dysmorphic mitochondria in glomerular cells. Biochemical analysis demonstrates decreased activity of the respiratory chain complexes II and III and decreased concentration of coenzyme Q10. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/31/43512?source=see_link\">",
"       \"Collapsing focal segmental glomerulosclerosis not associated with HIV infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In vitro studies have shown that the addition of quinone to cultured fibroblasts stimulated respiration and enzyme activities, suggesting that early coenzyme Q10 supplementation may result in clinical improvement for patients with coenzyme Q10 defects [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/44\">",
"       44",
"      </a>",
"      ]. In two siblings with coenzyme Q10 deficiency manifested by severe encephalopathy, nephrotic syndrome and renal failure, the administration of oral ubidecarenone (5",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      resulted in significant clinical improvement [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The PDSS2 gene encodes decaprenyl diphosphate synthase subunit 2, the first enzyme of the CoQ10 pathway. There is a single case report of this genetic mutation in a child with Leigh's syndrome who presented with steroid-resistant nephrotic syndrome at seven months of age [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/43\">",
"       43",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/37/602?source=see_link&amp;anchor=H21#H21\">",
"       \"Hereditary neuropathies associated with generalized disorders\", section on 'Leigh syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mutations in the",
"      <em>",
"       COQ6",
"      </em>",
"      gene, also involved in the CoQ10 pathway, have been reported in early onset steroid resistant nephrotic syndrome progressing to renal failure in association with hearing loss and encephalomyopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the",
"      <em>",
"       kd",
"      </em>",
"      mice model with a homozygous",
"      <em>",
"       PDSS2",
"      </em>",
"      mutation resulting in lower levels of CoQ9 and CoQ10, affected animals develop nephrotic syndrome, which progresses to end stage renal disease [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/47\">",
"       47",
"      </a>",
"      ]. Histologic analysis demonstrates signs of interstitial nephritis and focal glomerular sclerosis. CoQ10 supplementation rescues renal disease in this mouse [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Tubulointerstitial nephritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A chronic tubulointerstitial nephritis can occur in patients with mitochondrial cytopathies [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/11,21,49\">",
"     11,21,49",
"    </a>",
"    ]. These patients present with chronic renal insufficiency without signs of proximal tubular dysfunction. Polyuria with a urine concentrating defect has been observed. Renal biopsy shows a diffuse interstitial fibrosis with tubular atrophy and sclerosed glomeruli within the area of interstitial fibrosis. Extrarenal symptoms are commonly found.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of adults with mitochondrial cytopathy and renal involvement have been reported, with most having the A3243G mtDNA mutation associated with the MELAS syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/40,50-54\">",
"     40,50-54",
"    </a>",
"    ]. Females are four times more often affected than males. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=see_link&amp;anchor=H10#H10\">",
"     \"Mitochondrial myopathies: Clinical features and diagnosis\", section on 'MELAS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following renal features have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/40,50-52\">",
"     40,50-52",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The first renal symptoms occur in early adulthood and are the initial manifestations of the disease in one-third of cases.",
"     </li>",
"     <li>",
"      Proteinuria was accompanied by nephrotic syndrome in only one-third of cases. None of the patients had signs of tubular dysfunction.",
"     </li>",
"     <li>",
"      Most patients progressed to end-stage renal failure at a median age of 33 years.",
"     </li>",
"     <li>",
"      Renal biopsy most often showed nonspecific lesions, such as focal segmental glomerular sclerosis or tubulointerstitial lesions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Diabetes mellitus developed in the majority of patients, but usually several years after the nephropathy had been discovered. A positive family history of diabetes mellitus is reported frequently, but renal biopsy does not show any signs of diabetic glomerulopathy. In a cohort of 54 patients with type 2 diabetes mellitus and mutations of the A3243 mtDNA, 15 patients also had renal disease, whereas only 4 had diabetic retinopathy, suggesting that the nephropathy was due to mitochondrial cytopathy and not diabetic glomerulopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/8\">",
"     8",
"    </a>",
"    ]. In another study of 135 patients with diabetes and end-stage renal disease (ESRD), eight patients had A3243 mtDNA mutations, of which five subsequently developed symptoms characteristic of the MELAS syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/9\">",
"     9",
"    </a>",
"    ]. No A3243 mtDNA mutations were detected in 92 control patients with ESRD and not diabetes mellitus.",
"   </p>",
"   <p>",
"    Hearing loss is also a common finding, which often precedes the onset of renal disease and diabetes mellitus. The association of deafness and hereditary glomerulopathy explains why a number of patients had been diagnosed with Alport syndrome. However, a distinguishing feature is that patients with mitochondrial cytopathy do not have hematuria, which is a constant feature of Alport syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24663?source=see_link\">",
"     \"Genetics, pathogenesis, and pathology of hereditary nephritis (Alport syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     LABORATORY FINDINGS AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The investigation of patients with a suspected mitochondrial cytopathy includes measurement of the plasma levels of lactate, pyruvate, ketone bodies and their molar ratios, histochemical and electron microscopic studies on tissue from biopsy samples, and DNA analyses [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Oxidoreduction status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Determination of lactate, pyruvate, and ketone bodies and their molar ratios in plasma reflects the oxidoreduction status in cytoplasm and mitochondria. These determinations should be made in fasted and fed individuals or after an aerobic exercise test. A respiratory chain disorder is generally suggested by a persistent increase in lactate levels with elevations in the",
"    <span class=\"nowrap\">",
"     lactate/pyruvate",
"    </span>",
"    and ketone body molar ratios [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/56\">",
"     56",
"    </a>",
"    ]. However, these findings may be masked in patients with the de Toni-Debr&eacute;-Fanconi syndrome in whom the oxidoreduction status may be normal on account of the loss of organic acids in the urine. As a result, normal lactate levels do not rule out a mitochondrial disorder in patients with a proximal tubulopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/31/43513?source=see_link\">",
"     \"Overview of aerobic exercise testing in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following characteristic histologic features of mitochondrial disorders may be observed on biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence on muscle biopsy of ragged-red fibers, with irregularly shaped aggregates of abnormal mitochondria and lipid droplets between the fibrils [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/21\">",
"       21",
"      </a>",
"      ]. However, their absence does not exclude the diagnosis. These fibers may be seen using the modified Gomori trichrome technique.",
"     </li>",
"     <li>",
"      The presence of cytochrome-c-oxidase negative fibers.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Polarography and spectrophotometry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormal clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    metabolic data suggesting a mitochondrial cytopathy mandates direct investigation of the mitochondrial respiratory chain. This can be achieved by polarographic and spectrophotometric studies on mitochondria obtained from biopsied tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/57\">",
"     57",
"    </a>",
"    ]. These studies detect impaired respiration with different substrates and identify an enzymatic defect.",
"   </p>",
"   <p>",
"    Results are expressed as both absolute values and ratios, because a constant ratio of enzymatic activities is found in all tissues. Enzyme assays should be performed on the tissue or organ that clinically expresses the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/6\">",
"     6",
"    </a>",
"    ]. If such tissue is inaccessible, assays can be performed on circulating lymphocytes or cultured skin fibroblasts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     DNA analyses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Modern molecular biological techniques permit the detection of mitochondrial and genomic DNA abnormalities. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Large rearrangements of mtDNA can be diagnosed by Southern blot analysis",
"     </li>",
"     <li>",
"      Mitochondrial DNA point mutations can be detected using polymerase chain reaction amplification",
"     </li>",
"     <li>",
"      Genomic DNA abnormalities can be detected by sequencing DNA derived from various tissues",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These studies are not routine and negative results do not exclude the presence of a mtDNA mutation. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Genetics and disorders with renal involvement'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=see_link&amp;anchor=H23#H23\">",
"     \"Mitochondrial myopathies: Clinical features and diagnosis\", section on 'Molecular genetic studies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although no satisfactory treatment exists at present for mitochondrial cytopathies, patients should avoid drugs or activities that interfere with or strain respiratory chain function [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/55\">",
"     55",
"    </a>",
"    ]. Among the drugs that should be avoided are valproic acid, barbiturates, tetracyclines, and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?4/35/4664?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Lactic acidosis, exacerbated by exercise or intercurrent infections, can be treated with an infusion of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/56/41862?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    . Other symptomatic therapies include pancreatic extract for exocrine pancreatic dysfunction and transfusions, or, in patients with renal failure, erythropoietin for anemia.",
"   </p>",
"   <p>",
"    Several therapeutic agents may be effective in patients with known specific defects. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some patients with complex III deficiency improve with menadione (vitamin K3, 40 to 160",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      or ubidecarenone (coenzyme Q10, 80 to 300",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/58,59\">",
"       58,59",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Patients with complex I deficiency may be treated with riboflavin (100",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      and ubidecarenone [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/60\">",
"       60",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/11/22710?source=see_link\">",
"       Carnitine",
"      </a>",
"      is given to those with secondary carnitine deficiency",
"     </li>",
"     <li>",
"      Patients with cytochrome c oxidase deficiency should eat a low carbohydrate-high lipid diet",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other drug therapies include ascorbic acid (to lessen oxygen radical damage) and corticosteroids (for headaches and stroke-like episodes) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4520/abstract/61,62\">",
"     61,62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitochondrial cytopathies are a heterogeneous group of disorders characterized by genetic defects in one or more of the enzymatic complexes of the respiratory chain.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Because the genetic control of respiratory chain proteins, structure, and function is complex (",
"      <a class=\"graphic graphic_table graphicRef55067 \" href=\"UTD.htm?16/14/16621\">",
"       table 1",
"      </a>",
"      ), underlying genetic mutations have been identified in only a few patients with mitochondrial disorder and renal involvement. Both mitochondrial DNA (mtDNA) and nuclear DNA mutations are seen in patients with renal disease. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Genetics and disorders with renal involvement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Renal involvement is observed in 5 percent of patients with mitochondrial disorders. The most common renal manifestation is the de Toni-Debr&eacute;-Fanconi syndrome with impaired proximal tubular function that may lead to glucosuria, tubular proteinuria (including generalized amino aciduria), renal tubular acidosis, hypokalemia, and hypouricemia. Other less common renal manifestations include steroid-resistant nephrotic syndrome and chronic tubulointerstitial nephritis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Renal'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In adults with Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-like episodes (MELAS) syndrome and A3243G mtDNA mutation, renal symptoms occur in early adulthood and are the initial presentation in one-third of cases. These patients are also at risk for type 2 diabetes mellitus and hearing loss. Most patients will progress to end-stage renal disease (ESRD) at a median age of 33 years. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Adults'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of the primary mitochondrial disorders can be challenging because of the dual genomic origins (nuclear and mitochondrial), multisystem manifestations, and broad phenotypic heterogeneity encompassed by these conditions. The diagnosis is made based upon clinical findings and laboratory evaluation that includes measurement of the plasma levels of lactate, pyruvate, and ketone bodies, histologic and biochemical testing on tissue samples, and DNA analyses. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=see_link&amp;anchor=H16#H16\">",
"       \"Mitochondrial myopathies: Clinical features and diagnosis\", section on 'Evaluation and diagnosis'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H11\">",
"       'Laboratory findings and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no satisfactory treatment at present for mitochondrial cytopathies. Patients should avoid drugs (eg, valproic acid, barbiturates, tetracyclines, and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?4/35/4664?source=see_link\">",
"       chloramphenicol",
"      </a>",
"      ) or activities that interfere with or strain respiratory chain function. Some therapeutic agents or interventions may be effective in specific disorders. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/1\">",
"      Luft R. The development of mitochondrial medicine. Proc Natl Acad Sci U S A 1994; 91:8731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/2\">",
"      Johns DR. Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. N Engl J Med 1995; 333:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/3\">",
"      Niaudet P, Rotig A. The kidney in mitochondrial cytopathies. Kidney Int 1997; 51:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/4\">",
"      DiMauro S, Bonilla E, Lombes A, et al. Mitochondrial encephalomyopathies. Neurol Clin 1990; 8:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/5\">",
"      Wang J, Wilhelmsson H, Graff C, et al. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet 1999; 21:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/6\">",
"      R&ouml;tig A, Munnich A. Genetic features of mitochondrial respiratory chain disorders. J Am Soc Nephrol 2003; 14:2995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/7\">",
"      Mart&iacute;n-Hern&aacute;ndez E, Garc&iacute;a-Silva MT, Vara J, et al. Renal pathology in children with mitochondrial diseases. Pediatr Nephrol 2005; 20:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/8\">",
"      Guillausseau PJ, Massin P, Dubois-LaForgue D, et al. Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med 2001; 134:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/9\">",
"      Iwasaki N, Babazono T, Tsuchiya K, et al. Prevalence of A-to-G mutation at nucleotide 3243 of the mitochondrial tRNA(Leu(UUR)) gene in Japanese patients with diabetes mellitus and end stage renal disease. J Hum Genet 2001; 46:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/10\">",
"      Majander A, Suomalainen A, Vettenranta K, et al. Congenital hypoplastic anemia, diabetes, and severe renal tubular dysfunction associated with a mitochondrial DNA deletion. Pediatr Res 1991; 30:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/11\">",
"      R&ouml;tig A, Gouti&egrave;res F, Niaudet P, et al. Deletion of mitochondrial DNA in patient with chronic tubulointerstitial nephritis. J Pediatr 1995; 126:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/12\">",
"      D'Aco KE, Manno M, Clarke C, et al. Mitochondrial tRNA(Phe) mutation as a cause of end-stage renal disease in childhood. Pediatr Nephrol 2013; 28:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/13\">",
"      Carrozzo R, Bornstein B, Lucioli S, et al. Mutation analysis in 16 patients with mtDNA depletion. Hum Mutat 2003; 21:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/14\">",
"      Moraes CT, Shanske S, Tritschler HJ, et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991; 48:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/15\">",
"      Valnot I, von Kleist-Retzow JC, Barrientos A, et al. A mutation in the human heme A:farnesyltransferase gene (COX10 ) causes cytochrome c oxidase deficiency. Hum Mol Genet 2000; 9:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/16\">",
"      de Lonlay P, Valnot I, Barrientos A, et al. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet 2001; 29:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/17\">",
"      Munnich A, Rustin P, R&ouml;tig A, et al. Clinical aspects of mitochondrial disorders. J Inherit Metab Dis 1992; 15:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/18\">",
"      Neiberger RE, George JC, Perkins LA, et al. Renal manifestations of congenital lactic acidosis. Am J Kidney Dis 2002; 39:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/19\">",
"      Dinour D, Mini S, Polak-Charcon S, et al. Progressive nephropathy associated with mitochondrial tRNA gene mutation. Clin Nephrol 2004; 62:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/20\">",
"      Emma F, Bertini E, Salviati L, Montini G. Renal involvement in mitochondrial cytopathies. Pediatr Nephrol 2012; 27:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/21\">",
"      Egger J, Lake BD, Wilson J. Mitochondrial cytopathy. A multisystem disorder with ragged red fibres on muscle biopsy. Arch Dis Child 1981; 56:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/22\">",
"      R&ouml;tig A, Bessis JL, Romero N, et al. Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus, and cerebellar ataxia. Am J Hum Genet 1992; 50:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/23\">",
"      DiMauro S, Mendell JR, Sahenk Z, et al. Fatal infantile mitochondrial myopathy and renal dysfunction due to cytochrome-c-oxidase deficiency. Neurology 1980; 30:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/24\">",
"      Hurvitz H, Elpeleg ON, Barash V, et al. Glycogen storage disease, Fanconi nephropathy, abnormal galactose metabolism and mitochondrial myopathy. Eur J Pediatr 1989; 149:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/25\">",
"      Kitano A, Nishiyama S, Miike T, et al. Mitochondrial cytopathy with lactic acidosis, carnitine deficiency and DeToni-Fanconi-Debr&eacute; syndrome. Brain Dev 1986; 8:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/26\">",
"      Morris AA, Taylor RW, Birch-Machin MA, et al. Neonatal Fanconi syndrome due to deficiency of complex III of the respiratory chain. Pediatr Nephrol 1995; 9:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/27\">",
"      Niaudet P, Heidet L, Munnich A, et al. Deletion of the mitochondrial DNA in a case of de Toni-Debr&eacute;-Fanconi syndrome and Pearson syndrome. Pediatr Nephrol 1994; 8:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/28\">",
"      Ogier H, Lombes A, Scholte HR, et al. de Toni-Fanconi-Debr&eacute; syndrome with Leigh syndrome revealing severe muscle cytochrome c oxidase deficiency. J Pediatr 1988; 112:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/29\">",
"      Szabolcs MJ, Seigle R, Shanske S, et al. Mitochondrial DNA deletion: a cause of chronic tubulointerstitial nephropathy. Kidney Int 1994; 45:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/30\">",
"      Van Biervliet JP, Bruinvis L, Ketting D, et al. Hereditary mitochondrial myopathy with lactic acidemia, a De Toni-Fanconi-Debr&eacute; syndrome, and a defective respiratory chain in voluntary striated muscles. Pediatr Res 1977; 11:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/31\">",
"      Eviatar L, Shanske S, Gauthier B, et al. Kearns-Sayre syndrome presenting as renal tubular acidosis. Neurology 1990; 40:1761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/32\">",
"      Gruskin AB, Patel MS, Linshaw M, et al. Renal function studies and kidney pyruvate carboxylase in subacute necrotizing encephalomyelopathy (Leigh's syndrome). Pediatr Res 1973; 7:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/33\">",
"      Matsutani H, Mizusawa Y, Shimoda M, et al. Partial deficiency of cytochrome c oxidase with isolated proximal renal tubular acidosis and hypercalciuria. Child Nephrol Urol 1992; 12:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/34\">",
"      Katsanos KH, Elisaf M, Bairaktari E, Tsianos EV. Severe hypomagnesemia and hypoparathyroidism in Kearns-Sayre syndrome. Am J Nephrol 2001; 21:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/35\">",
"      Emma F, Pizzini C, Tessa A, et al. \"Bartter-like\" phenotype in Kearns-Sayre syndrome. Pediatr Nephrol 2006; 21:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/36\">",
"      Goto Y, Itami N, Kajii N, et al. Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome. J Pediatr 1990; 116:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/37\">",
"      Menegon LF, Amaral TN, Gontijo JA. Renal sodium handling study in an atypical case of Bartter's syndrome associated with mitochondriopathy and sensorineural blindness. Ren Fail 2004; 26:195.",
"     </a>",
"    </li>",
"    <li>",
"     Brun P, Ogier de Baulny H, Peuchmaur, et al. Les atteintes r&eacute;nales des cytopathies mitochondriales. In: Journ&eacute;es Parisiennes de P&eacute;diatrie, Flammarion M&eacute;decine Sciences, Paris 1994. p.227.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/39\">",
"      R&ouml;tig A, Lehnert A, Rustin P, et al. Kidney involvement in mitochondrial disorders. Adv Nephrol Necker Hosp 1995; 24:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/40\">",
"      Doleris LM, Hill GS, Chedin P, et al. Focal segmental glomerulosclerosis associated with mitochondrial cytopathy. Kidney Int 2000; 58:1851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/41\">",
"      Diomedi-Camassei F, Di Giandomenico S, Santorelli FM, et al. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 2007; 18:2773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/42\">",
"      Barisoni L, Diomedi-Camassei F, Santorelli FM, et al. Collapsing glomerulopathy associated with inherited mitochondrial injury. Kidney Int 2008; 74:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/43\">",
"      L&oacute;pez LC, Schuelke M, Quinzii CM, et al. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet 2006; 79:1125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/44\">",
"      Montini G, Malaventura C, Salviati L. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med 2008; 358:2849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/45\">",
"      R&ouml;tig A, Appelkvist EL, Geromel V, et al. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 2000; 356:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/46\">",
"      Heeringa SF, Chernin G, Chaki M, et al. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest 2011; 121:2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/47\">",
"      Peng M, Falk MJ, Haase VH, et al. Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease. PLoS Genet 2008; 4:e1000061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/48\">",
"      Saiki R, Lunceford AL, Shi Y, et al. Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2. Am J Physiol Renal Physiol 2008; 295:F1535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/49\">",
"      Donaldson MD, Warner AA, Trompeter RS, et al. Familial juvenile nephronophthisis, Jeune's syndrome, and associated disorders. Arch Dis Child 1985; 60:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/50\">",
"      Gu&eacute;ry B, Choukroun G, No&euml;l LH, et al. The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation. J Am Soc Nephrol 2003; 14:2099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/51\">",
"      Hotta O, Inoue CN, Miyabayashi S, et al. Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation. Kidney Int 2001; 59:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/52\">",
"      Jansen JJ, Maassen JA, van der Woude FJ, et al. Mutation in mitochondrial tRNA(Leu(UUR)) gene associated with progressive kidney disease. J Am Soc Nephrol 1997; 8:1118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/53\">",
"      Kurogouchi F, Oguchi T, Mawatari E, et al. A case of mitochondrial cytopathy with a typical point mutation for MELAS, presenting with severe focal-segmental glomerulosclerosis as main clinical manifestation. Am J Nephrol 1998; 18:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/54\">",
"      Nakamura S, Yoshinari M, Doi Y, et al. Renal complications in patients with diabetes mellitus associated with an A to G mutation of mitochondrial DNA at the 3243 position of leucine tRNA. Diabetes Res Clin Pract 1999; 44:183.",
"     </a>",
"    </li>",
"    <li>",
"     Hammans SR, Morgan-Hughes JA. Mitochondrial myopathies: Clinical features, investigation, treatment and genetic counseling. In: Mitochondrial Disorders in Neurology, Schapira AHV, DiMauro S (Eds), Butterworth Heinemann, Oxford 1994. p.49.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/56\">",
"      Chretien D, Bourgeron T, R&ouml;tig A, et al. The measurement of the rotenone-sensitive NADH cytochrome c reductase activity in mitochondria isolated from minute amount of human skeletal muscle. Biochem Biophys Res Commun 1990; 173:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/57\">",
"      Rustin P, Chretien D, Bourgeron T, et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994; 228:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/58\">",
"      Bresolin N, Doriguzzi C, Ponzetto C, et al. Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial. J Neurol Sci 1990; 100:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/59\">",
"      Argov Z, Bank WJ, Maris J, et al. Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study. Ann Neurol 1986; 19:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/60\">",
"      Arts WF, Scholte HR, Bogaard JM, et al. NADH-CoQ reductase deficient myopathy: successful treatment with riboflavin. Lancet 1983; 2:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/61\">",
"      Shapira Y, Cederbaum SD, Cancilla PA, et al. Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia. Neurology 1975; 25:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4520/abstract/62\">",
"      Gubbay SS, Hankey GJ, Tan NT, Fry JM. Mitochondrial encephalomyopathy with corticosteroid dependence. Med J Aust 1989; 151:100.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6082 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-197.136.42.3-A67B6C3D87-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4520=[""].join("\n");
var outline_f4_26_4520=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MITOCHONDRIAL RESPIRATORY CHAIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      GENETICS AND DISORDERS WITH RENAL INVOLVEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL CHARACTERISTICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Extrarenal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Renal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Tubular disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Glomerular disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Tubulointerstitial nephritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LABORATORY FINDINGS AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Oxidoreduction status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Polarography and spectrophotometry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DNA analyses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6082\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6082|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/14/16621\" title=\"table 1\">",
"      Genetics of mitochondrial myopathies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/31/43512?source=related_link\">",
"      Collapsing focal segmental glomerulosclerosis not associated with HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24663?source=related_link\">",
"      Genetics, pathogenesis, and pathology of hereditary nephritis (Alport syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/37/602?source=related_link\">",
"      Hereditary neuropathies associated with generalized disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=related_link\">",
"      Mitochondrial myopathies: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12853?source=related_link\">",
"      Mitochondrial structure, function, and genetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/31/43513?source=related_link\">",
"      Overview of aerobic exercise testing in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_26_4521="Electrocardiogram in the prognosis of myocardial infarction or unstable angina";
var content_f4_26_4521=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Electrocardiogram in the prognosis of myocardial infarction or unstable angina",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/26/4521/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/26/4521/contributors\">",
"     Ary L Goldberger, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/26/4521/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/26/4521/contributors\">",
"     Juan Carlos Kaski, MD, DM, DSc, FRCP, FESC, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/26/4521/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/26/4521/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/26/4521/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 10, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The electrocardiogram (ECG) is a mainstay in the diagnosis of acute and chronic coronary syndromes. The findings depend upon several key factors including the duration",
"    <span class=\"nowrap\">",
"     (hyperacute/acute",
"    </span>",
"    versus",
"    <span class=\"nowrap\">",
"     evolving/chronic),",
"    </span>",
"    extent (Q wave versus non-Q wave), and localization (anterior versus inferior-posterior and the size of the ischemic or infarcted region) of ischemia or infarction, as well as the presence of other underlying abnormalities. The ECG also provides information on prognosis.",
"   </p>",
"   <p>",
"    The use of the ECG for prognosis in myocardial infarction or unstable angina will be reviewed here. Use of the ECG for diagnosis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=see_link\">",
"     \"Electrocardiogram in the diagnosis of myocardial ischemia and infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to the findings on the ECG, a number of other parameters are of prognostic importance in patients with myocardial infarction or unstable angina. Among the poor prognostic factors are cardiogenic shock, a reduced left ventricular ejection fraction, and certain types of arrhythmias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL ISSUES OF RISK STRATIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The process of risk stratification in a patient who has had an acute myocardial infarction (MI) has several components:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early in-hospital identification of patients at increased risk for recurrent ischemic events.",
"     </li>",
"     <li>",
"      Identification of patients at increased risk for arrhythmic or nonarrhythmic death; arrhythmias, for example, are the most frequent cause of death during the first year after an MI.",
"     </li>",
"     <li>",
"      Identification of patients at high risk of developing other complications such as heart failure and shock.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These issues are discussed elsewhere in a variety of topics:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For early risk stratification after an ST elevation (Q wave) MI (STEMI) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/52/35658?source=see_link\">",
"       \"Risk stratification for cardiac events after acute ST elevation myocardial infarction\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For early risk stratification after a non-ST elevation (non-Q wave) MI (NSTEMI) or unstable angina (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25754?source=see_link\">",
"       \"Risk factors for adverse outcomes after unstable angina or non-ST elevation myocardial infarction\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      For risk stratification for late cardiovascular mortality (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/24/20874?source=see_link\">",
"       \"Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      For general prognosis after an MI (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44361?source=see_link&amp;anchor=H20#H20\">",
"       \"Epidemiology of coronary heart disease\", section on 'Prognosis'",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     STEMI VERSUS NSTEMI AND UNSTABLE ANGINA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The extent and severity of ischemia are the primary determinant of ST changes that occur in an acute coronary syndrome (ACS). Primary ST elevation is generally associated with transmural ischemia while ST depression (not related to reciprocal changes) is associated with ischemia limited to the subendocardium. As will be described below, marked ST elevation or depression in multiple leads usually indicates very severe and widespread ischemia and therefore a worse outcome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=see_link\">",
"     \"Electrocardiogram in the diagnosis of myocardial ischemia and infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Necrosis of sufficient myocardial tissue can lead to decreased R wave amplitude or frank Q waves due to loss of electromotive forces in the infarcted area. Thus, the reason why Q waves do or do not develop following coronary occlusion is related to the duration of occlusion, the area of myocardium at risk, and the extent to which myocardial viability is maintained during occlusion by remaining anterograde blood flow and the function of collaterals. The infarct-related artery is occluded in over 90 percent of cases. In contrast, coronary arteriography performed in the acute period of NSTEMI has shown that the infarct-related artery is not occluded in 60 to 85 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/0/36868?source=see_link\">",
"     \"Pathogenesis and diagnosis of Q waves on the electrocardiogram\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Short-term and long-term outcomes are better in patients with unstable angina than in those with an MI. Among patients with an MI, NSTEMI is associated with a lower in-hospital mortality but a similar or worse long-term outcome than ST elevation infarcts. The worse short-term outcome with STEMI reflects a larger infarction that is presumably due to the much higher rate of complete occlusion of the infarct-related artery with STEMI than with NSTEMI. The similar or worse late prognosis with NSTEMI is in part related to a more than 50 percent prevalence of multivessel disease in patients with an NSTEMI [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/1\">",
"     1",
"    </a>",
"    ] and a higher rate of recurrent ischemia and infarction than with STEMI [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/5\">",
"     5",
"    </a>",
"    ]. Thus, a significant amount of myocardium remains at risk. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44361?source=see_link&amp;anchor=H11#H11\">",
"     \"Epidemiology of coronary heart disease\", section on 'CHD mortality'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ECG FOR PROGNOSIS IN STEMI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prognostic factors for STEMI and NSTEMI differ. In addition to identifying the location of the infarction, the initial ECG can give important information regarding severity and prognosis in patients with an STEMI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Extent of myocardial injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;A multivariate analysis from the GUSTO-I database of 41,021 patients found that the following ECG variables were predictive of 30 day mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sum of the absolute ST-segment deviation, both elevation and depression, &ge;19 mm (odds ratio 1.53)",
"     </li>",
"     <li>",
"      Evidence of prior infarction for new inferior infarction (odds ratio 2.47)",
"     </li>",
"     <li>",
"      Heart rate &gt;84 beats per min (odds ratio 1.49)",
"     </li>",
"     <li>",
"      QRS duration &ge;100 msec for anterior infarction (odds ratio 1.55)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Each of these parameters, particularly the first two, is at least in part related to the extent of myocardial injury. This issue was addressed more directly in an analysis from the GISSI-1 trial, which confirmed the value of ST segment elevations observed on the admission ECG in predicting in-hospital mortality, as well as mortality at both 30 days and long-term in patients with a first MI [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/7\">",
"     7",
"    </a>",
"    ]. Four distinct severity groups were defined based upon the number of ECG leads with ST elevation: two to three leads, four to five leads, six to seven leads, and more than eight leads. In-hospital, 30-day and 10-year mortality increased progressively as the number of ECG leads with ST elevation increased, although not all differences were statistically significant. Furthermore, patients with more extensive disease showed greater benefit from thrombolytic therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Anterior MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anterior wall infarction is associated with a worse prognosis than inferior wall infarction mostly because of larger infarct size [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/8-12\">",
"     8-12",
"    </a>",
"    ]. In one report that included both ST elevation and non-ST elevation infarctions, anterior infarcts had the following significant differences from inferior infarcts: a lower admission left ventricular ejection fraction (38 versus 55 percent), and higher incidences of heart failure (41 versus 15 percent), serious ventricular arrhythmias, in-hospital mortality (11.9 versus 2.8 percent), and, at a mean duration of 30 months, total cardiac mortality (27 versus 11 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar findings were noted in a report from the SPRINT registry of patients with a first NSTEMI [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/9\">",
"     9",
"    </a>",
"    ]. Patients with an anterior infarction had a higher rate of in-hospital complications (HF and cardiogenic shock), and a higher in-hospital mortality (15 versus 10 percent) when compared to those with a less extensive",
"    <span class=\"nowrap\">",
"     inferior/lateral",
"    </span>",
"    wall infarctions. They also had a higher one-year rate of recurrent infarction or cardiac death (14.2 versus 4.8 percent) and a higher five-year mortality (36 versus 22 percent). After adjustment for other risk factors, most of these differences did not reach statistical significance except for a higher one year cardiac event rate (odds ratio 3.15, 95 percent confidence interval 1.59 to 6.78).",
"   </p>",
"   <p>",
"    As a result of these and other findings, anterior wall infarction has been included as a risk factor in the TIMI risk scores for both STEMI (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?27/53/28497?source=see_link\">",
"     calculator 1",
"    </a>",
"    ) and non-ST elevation ACS (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?5/34/5665?source=see_link\">",
"     calculator 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/52/35658?source=see_link\">",
"     \"Risk stratification for cardiac events after acute ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/43/2746?source=see_link&amp;anchor=H7#H7\">",
"     \"Risk stratification after unstable angina or non-ST elevation myocardial infarction\", section on 'TIMI risk score'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Inferior MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;The importance of the extent of injury also applies to inferior infarcts. A report from the GUSTO-I trial evaluated 16,521 patients with an acute inferior wall STEMI [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/16\">",
"     16",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Precordial ST segment depressions were associated with larger infarctions, more postinfarction complications (heart failure, second or third degree heart block, or shock) and a small but significant increase in mortality rate at 30 days and one year when compared to the absence of these changes. After adjustment for clinical risk factors, the magnitude of the ST depression (sum of leads V1-V6) added significant independent prognostic information as the 30 day mortality increased by 36 percent for every 0.5 mV (5 mm) increment in summed precordial ST segment depression.",
"     </li>",
"     <li>",
"      Patients with ST segment depression in leads V4-V6 were more likely to have three-vessel disease than were those with ST depression in leads V1-V3 or those without precordial ST segment depression (36 versus 16 and 14 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/17\">",
"       17",
"      </a>",
"      ]. Such patients derive greater absolute benefit from reperfusion therapy with thrombolytic agents or angioplasty because they have a larger amount of myocardium at risk [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     QRS morphology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Distinct QRS morphologies may also provide information relating to infarct size and prognosis. Data from the TIMI-4 trial suggested that the following distortions of the terminal portion of the QRS complex in two or more adjacent leads may be particularly informative [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/19\">",
"     19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tall symmetric upright T waves and ST segment elevation accompanied, in leads with an initial QR configuration, by the J point at &ge;50 percent of the R wave amplitude (measured from the isoelectric line).",
"     </li>",
"     <li>",
"      Absence of S waves in leads without Q waves (an Rs configuration).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with these abnormalities had larger infarct sizes and larger defects on Tc-99m sestamibi scans than those without these findings. These patients had a higher mortality at one year (18 versus 6 percent, p = 0.03) and an increasing trend for the end points of death, reinfarction, heart failure, and an ejection fraction of less than 40 percent. The risk was greatest in patients with these QRS findings who had an anterior wall infarction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Presence or absence of new Q waves",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although STEMI is typically associated with the evolution of pathologic Q waves, some patients do not develop new Q waves. This is an important issue since the appearance of new Q waves in the setting of STEMI predicts both a larger infarct and increased mortality.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an initial report of 150 patients presenting with STEMI, 115 (77 percent) developed Q waves during the hospitalization; none of the patients was treated with reperfusion (thrombolytic therapy or primary percutaneous coronary intervention) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/20\">",
"       20",
"      </a>",
"      ]. The patients who developed Q waves had a significantly lower rate of patency of the infarct-related artery (24 versus 57 percent) and a larger infarction as demonstrated by a higher peak serum CK (1372 versus 664",
"      <span class=\"nowrap\">",
"       IU/L)",
"      </span>",
"      and a lower left ventricular ejection fraction before discharge (46 versus 54 percent).",
"     </li>",
"     <li>",
"      In a cohort of 4530 patients with STEMI treated with primary PCI, 56 percent had Q waves on presentation [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/21\">",
"       21",
"      </a>",
"      ]. Patients with Q waves had a significantly higher mortality at 90 days compared with those who did not develop Q waves (5.3 versus 2.1 percent). The presence or absence of Q waves was a better predictor of mortality at 90 days than time from symptom onset to PCI.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Persistent absence of Q waves after thrombolytic therapy also predicts a less severe infarction and better outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/22-25\">",
"     22-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 21,570 patients enrolled in the GUSTO-I trial of thrombolysis who did not have confounding ECG factors or a prior MI, Q waves did not develop in 4601 (21.3 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/22\">",
"       22",
"      </a>",
"      ]. Compared to the Q wave group, patients with a non-Q wave STEMI had a significantly lower rate of heart failure (8.5 versus 13.9 percent) and significant reductions in mortality in-hospital and at 30 days (adjusted mortality 4.8 versus 5.3 percent) and one year.",
"     </li>",
"     <li>",
"      In a second subset analysis from GUSTO-I, patients without Q waves had a significantly higher left ventricular ejection fraction (66 versus 57 percent) and higher rates of survival at all time points including two years (6.3 versus 10.1 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/23\">",
"       23",
"      </a>",
"      ]. The infarct-related artery was significantly less likely to be anterior (33 versus 42 percent) and more likely to be distal. The degree of reperfusion was greater as evidenced by a higher likelihood of early (77 versus 65 percent at 90 minutes) and complete patency in the infarct-related artery (54 versus 44 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     R waves",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extensive loss of R waves on the ECG is usually seen in patients with an anterior MI, and there is a rough correlation between the sum of R wave voltages in all 12 ECG leads and the LVEF. Patients with diminished total R wave voltage, defined as less than 4 mm total in ECG leads AVL, AVF, and V1-V6 in the absence of bundle branch block (BBB), have significantly reduced LV dysfunction and a worse prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/26\">",
"     26",
"    </a>",
"    ]. More complex formulae employing summated R waves and Q waves that produce a more accurate prediction of LVEF exist [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Resolution of ST and T wave changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The outcome after acute STEMI is improved in patients who have resolution of ST and T wave changes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     ST segment elevation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the era of percutaneous coronary intervention and fibrinolytic therapy, resolution of ST segment elevation in patients with an STEMI [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/28\">",
"     28",
"    </a>",
"    ] is a marker of reperfusion and coronary artery patency (as estimated from TIMI flow grade) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/29\">",
"     29",
"    </a>",
"    ] and is associated with smaller infarct size [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/30\">",
"     30",
"    </a>",
"    ]. Lack of ST segment resolution by 90 to 180 minutes and the amount of ST deviation persisting at 90 minutes are powerful clinical predictors of 35 day, six month, one year, and long-term mortality (",
"    <a class=\"graphic graphic_figure graphicRef73003 graphicRef75462 \" href=\"UTD.htm?30/4/30799\">",
"     figure 1A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/29,31\">",
"     29,31",
"    </a>",
"    ]. The importance of ST segment elevation resolution is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/38/7786?source=see_link&amp;anchor=H7#H7\">",
"     \"Fibrinolytic (thrombolytic) agents in acute ST elevation myocardial infarction: Markers of efficacy\", section on 'ST segment elevation resolution'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/46/16106?source=see_link&amp;anchor=H30#H30\">",
"     \"Primary percutaneous coronary intervention in acute ST elevation myocardial infarction: Determinants of outcome\", section on 'Prognosis after primary PCI'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     ST segment depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;ST segment depression (in leads other than those initially showing ST segment elevation) is commonly seen in patients with an ST segment elevation infarction. This may reflect ischemia in a second myocardial region or reciprocal changes from the region with ST elevation. As indicated above, its presence is associated with a larger infarct and a poorer prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/6,16,17\">",
"     6,16,17",
"    </a>",
"    ]. The course of these changes after an MI is also of prognostic importance.",
"   </p>",
"   <p>",
"    This was illustrated in a series of 261 patients presenting with an acute myocardial infarction which evaluated the timing of ST segment depression resolution relative to the resolution of ST segment elevation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/32\">",
"     32",
"    </a>",
"    ]. In-hospital mortality was significantly higher in patients who had ST segment depression that persisted after resolution of ST segment elevation compared to those with simultaneous resolution of ST segment depression and elevation or those without ST segment depression (13 versus 1 and 0 percent, respectively, p = 0.002). The incidence of recurrent angina, reinfarction, and heart failure was similar among the three groups.",
"   </p>",
"   <p>",
"    In another report, persistence of ST segment depression in V5 to V6 for more than six months after an anterior infarction was associated with diastolic dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     T wave inversion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serial ECG changes may also predict postinfarction remodeling [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/34\">",
"     34",
"    </a>",
"    ]. Lack of negative T wave resolution and late appearance of new negative T waves predict more pronounced left ventricular enlargement and progressive deterioration of ventricular function. In contrast, normalization of T waves is related to functional recovery of viable myocardium and may be more predictive than QRS changes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Conduction abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of conduction abnormalities, including AV block and bundle branch block, are associated with acute MI and may have prognostic significance. This issue is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/11/4282?source=see_link\">",
"     \"Conduction abnormalities after myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ECG FOR PROGNOSIS IN UA AND NSTEMI",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, patients with a NSTEMI have a lower in-hospital mortality but similar or worse long-term outcomes than those with ST elevation infarcts. Patients with unstable angina without evidence of infarction have a better prognosis than do either infarct group (",
"    <a class=\"graphic graphic_figure graphicRef61809 \" href=\"UTD.htm?32/35/33341\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/5,8,35,36\">",
"     5,8,35,36",
"    </a>",
"    ]. Among patients with a non-ST elevation ACS, the ECG can identify patients in different risk categories. The major factors are the presence, extent, and location of ST segment depression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44361?source=see_link\">",
"     \"Epidemiology of coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/43/2746?source=see_link\">",
"     \"Risk stratification after unstable angina or non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     ST segment depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;ST segment depression is associated with a worse outcome than T wave inversion alone or no ECG changes, and it is one of the adverse risk factors in the TIMI risk score (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?27/53/28497?source=see_link\">",
"     calculator 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/15,37-41\">",
"     15,37-41",
"    </a>",
"    ]. ST segment depression also identifies patients who are more likely to benefit from an early invasive strategy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29722?source=see_link\">",
"     \"Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The importance of ST depression for prognosis was demonstrated in an analysis from GUSTO-IIb of over 12,000 patients presenting with symptoms of cardiac ischemia at rest that was confirmed by ECG; only about one-third underwent revascularization, a value much lower than current clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/37\">",
"     37",
"    </a>",
"    ]. The 30 day incidence of death or myocardial infarction was significantly higher in patients with ST depression (10.5 versus 5.5 percent in those with T wave inversion alone, adjusted odds ratio 1.62). This difference in mortality persisted at six months (15.4 versus 8.1 percent).",
"   </p>",
"   <p>",
"    ST segment depression also has long term predictive value [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/38-40,44\">",
"     38-40,44",
"    </a>",
"    ]. This was illustrated in a review of 1416 patients with a non-ST elevation acute coronary syndrome in the TIMI-III study registry [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/38\">",
"     38",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Death or recurrent MI at one year was significantly more common in patients with ST segment deviation (depression or elevation) &ge;1 mm compared to those with isolated T wave inversions or no ECG changes (11 versus 6.8 and 8.2 percent).",
"     </li>",
"     <li>",
"      Anterior ST segment changes carried the worst prognosis, while the location of T wave inversions did not correlate with outcome.",
"     </li>",
"     <li>",
"      Patients with left bundle branch block and the presence of only 0.5 mm ST segment deviation were also at increased risk.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to its presence, the extent of ST segment depression also has prognostic value. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Extent of myocardial ischemia'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Recurrence or persistence of ST segment depression also appears to predict a poorer outcome. In a review of 515 patients who survived hospitalization after a confirmed NSTEMI, mortality during one year follow-up was 5.5 percent in patients with no ST depression, 10 percent in those with ST depression at baseline or discharge, and 22 percent in those with ST depression at baseline and discharge (persistent ST segment depression) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     T wave inversion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with a non-ST elevation acute coronary syndrome, the short-term prognosis appears to be better in those who present with T wave inversion alone compared to ST segment depression [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/37,40,46\">",
"     37,40,46",
"    </a>",
"    ]. This was illustrated in an analysis from GUSTO-IIb in which the 30-day incidence of death or reinfarction in patients with T wave inversion alone on the initial ECG (22 percent of patients) was significantly lower than in those with ST depression (5.5 versus 10.5 percent, adjusted odds ratio 0.62) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Extent of myocardial ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with unstable angina or a non-ST segment elevation MI, the magnitude, location, and extent of ST segment depression, a reflection of the extent of myocardial ischemia, are associated with increased mortality. This was demonstrated in a logistic regression model that used data from the PARAGON-A trial and was then applied to 8001 patients in GUSTO-IIb trial [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/39\">",
"     39",
"    </a>",
"    ]. The presence of &ge;2 mm ST segment depression was associated with a significant increase in the risk of death at one year (14 versus 4.4 percent for no ST segment depression, adjusted odds ratio 5.73) (",
"    <a class=\"graphic graphic_figure graphicRef58461 \" href=\"UTD.htm?21/12/21710\">",
"     figure 3",
"    </a>",
"    ), while its presence in more than one region was associated with a mortality of 20 percent (adjusted odds ratio 9.2).",
"   </p>",
"   <p>",
"    Additional short-term prognostic indicators related to the extent of myocardial ischemia have been identified in other studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a review of admission ECGs from almost 5200 patients in the GUSTO-IIb trial, the sum of ST segment depression in all leads was a powerful independent predictor of 30-day mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/41\">",
"       41",
"      </a>",
"      ]. The risk increased continuously with increasing ST segment depression: 30-day mortality in the top quartile (&gt;6 mm) compared to the bottom quartile (0 to 2 mm) was 6.3 and 1.6 percent, respectively. Even minimal (&lt;1 mm) ST segment elevation in anterior or inferior leads was also an adverse predictor.",
"     </li>",
"     <li>",
"      In a series of 516 patients with unstable coronary disease, ST segment depression or inverted T waves in five or more leads at the time of hospital admission was the only independent predictor of death or myocardial infarction at 30 days [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a report of 432 patients with a first acute NSTEMI, the only ECG finding predictive of in-hospital outcome was ST segment depression in two or more lateral leads (I, aVL, V5, or V6) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/48\">",
"       48",
"      </a>",
"      ]. Such patients had much higher rates of in-hospital mortality (14.3 versus 2.6 percent without lateral ST segment depression), severe heart failure (14.3 versus 4.1 percent), and left main or three-vessel coronary disease in those who were catheterized (60 versus 22 percent). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/20/4426?source=see_link\">",
"       \"Management of left main coronary artery disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The extent of myocardial ischemia as determined by measurement of ST segment depression also predicts which patients with a non-ST elevation ACS will benefit most from an invasive treatment strategy. In an analysis of ECGs from 2201 patients participating in the FRISC-II trial, patients were stratified according to the sum of ST segment deviation in all leads (0 to 2.5 mm, 3 to 5.5 mm, or &ge;6 mm) and according to the number of leads with ST segment deviation (0 to 4, 5 to 7, or &ge;8 leads) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/49\">",
"     49",
"    </a>",
"    ]. At one year, the rate of death or MI was significantly lower with an invasive strategy for those patients with the greatest extent of myocardial ischemia by ST segment sum (9.5 versus 19.4 percent) or by number of affected leads (8.5 versus 19.2 percent); there was no statistical benefit from invasive therapy in patients with the least extent of ischemia by ST segment scoring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     AV block",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most reports that have assessed the incidence and prognostic significance of high degree AV block after MI have not distinguished between STEMI and NSTEMI. In a review of 610 patients with a first non-Q wave MI, second or third degree AV block developed in 7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/50\">",
"     50",
"    </a>",
"    ]. High degree AV block was associated with larger and more complicated infarctions, similar to the observation in ST elevation infarcts (see",
"    <a class=\"local\" href=\"#H16\">",
"     'Conduction abnormalities'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     New Q waves",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with non-ST elevation acute coronary syndromes can develop new Q waves, which are associated with a worse prognosis. These relationships were illustrated in a review of 10,501 such patients who had survived 30 days: the 30-day ECG (compared to the baseline ECG) revealed new 30 to 40 msec Q waves in 7 percent and new &ge;40 msec Q waves in 3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/26/4521/abstract/44\">",
"     44",
"    </a>",
"    ]. At six months, there was a nonsignificant increase in mortality in the patients with new 30 to 40 msec Q waves (3.4 versus 2.4 percent with no new Q waves, adjusted odds ratio 1.30, 95% CI 0.85-1.30) and a significant increase in mortality in those with new &ge;40 msec Q waves (5.3 versus 2.4 percent, adjusted odds ratio 1.87, 95% CI 1.13-3.09). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=see_link&amp;anchor=H7#H7\">",
"     \"Electrocardiogram in the diagnosis of myocardial ischemia and infarction\", section on 'Criteria for abnormal Q waves'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16895552\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    In patients with ST-elevation myocardial infarction (STEMI), the following electrocardiographic features appear to predict a worse outcome:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The extent of myocardial injury as measured by the sum of the absolute ST-segment deviation, evidence of prior infarction, heart rate &gt;84 beats per minute, and QRS width &ge;100 msec for anterior infarction. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Extent of myocardial injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Presence of new Q waves. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Presence or absence of new Q waves'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lack of resolution of ST and T wave changes. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Resolution of ST and T wave changes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with non-ST elevation acute coronary syndromes, the following electrocardiographic features appear to predict a worse outcome:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      ST segment depression compared with just T wave inversion. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'ST segment depression'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'T wave inversion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Magnitude and extent of the ST segment depression. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'ST segment depression'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/1\">",
"      Liebson PR, Klein LW. The non-Q wave myocardial infarction revisited: 10 years later. Prog Cardiovasc Dis 1997; 39:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/2\">",
"      Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation 1993; 87:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/3\">",
"      Kerensky RA, Wade M, Deedwania P, et al. Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol 2002; 39:1456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/4\">",
"      Wong GC, Morrow DA, Murphy S, et al. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction. Circulation 2002; 106:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/5\">",
"      Armstrong PW, Fu Y, Chang WC, et al. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation 1998; 98:1860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/6\">",
"      Hathaway WR, Peterson ED, Wagner GS, et al. Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. JAMA 1998; 279:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/7\">",
"      Mauri F, Franzosi MG, Maggioni AP, et al. Clinical value of 12-lead electrocardiography to predict the long-term prognosis of GISSI-1 patients. J Am Coll Cardiol 2002; 39:1594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/8\">",
"      Stone PH, Raabe DS, Jaffe AS, et al. Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. J Am Coll Cardiol 1988; 11:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/9\">",
"      Haim M, Hod H, Reisin L, et al. Comparison of short- and long-term prognosis in patients with anterior wall versus inferior or lateral wall non-Q-wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group. Am J Cardiol 1997; 79:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/10\">",
"      Becker RC, Burns M, Gore JM, et al. Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) Participants. Am Heart J 1998; 135:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/11\">",
"      Califf RM, Pieper KS, Lee KL, et al. Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation 2000; 101:2231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/12\">",
"      Fresco C, Carinci F, Maggioni AP, et al. Very early assessment of risk for in-hospital death among 11,483 patients with acute myocardial infarction. GISSI investigators. Am Heart J 1999; 138:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/13\">",
"      Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000; 102:2031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/14\">",
"      Morrow DA, Antman EM, Parsons L, et al. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA 2001; 286:1356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/15\">",
"      Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000; 284:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/16\">",
"      Peterson ED, Hathaway WR, Zabel KM, et al. Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients. J Am Coll Cardiol 1996; 28:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/17\">",
"      Birnbaum Y, Wagner GS, Barbash GI, et al. Correlation of angiographic findings and right (V1 to V3) versus left (V4 to V6) precordial ST-segment depression in inferior wall acute myocardial infarction. Am J Cardiol 1999; 83:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/18\">",
"      Evans MA, Clements IP, Christian TF, Gibbons RJ. Association between anterior ST depression and increased myocardial salvage following reperfusion therapy in patients with inferior myocardial infarction. Am J Med 1998; 104:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/19\">",
"      Birnbaum Y, Kloner RA, Sclarovsky S, et al. Distortion of the terminal portion of the QRS on the admission electrocardiogram in acute myocardial infarction and correlation with infarct size and long-term prognosis (Thrombolysis in Myocardial Infarction 4 Trial). Am J Cardiol 1996; 78:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/20\">",
"      Huey BL, Gheorghiade M, Crampton RS, et al. Acute non-Q wave myocardial infarction associated with early ST segment elevation: evidence for spontaneous coronary reperfusion and implications for thrombolytic trials. J Am Coll Cardiol 1987; 9:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/21\">",
"      Armstrong PW, Fu Y, Westerhout CM, et al. Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2009; 53:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/22\">",
"      Barbagelata A, Califf RM, Sgarbossa EB, et al. Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators. J Am Coll Cardiol 1997; 29:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/23\">",
"      Goodman SG, Langer A, Ross AM, et al. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators. Circulation 1998; 97:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/24\">",
"      Lockwood E, Fu Y, Wong B, et al. Does 24-hour ST-segment resolution postfibrinolysis add prognostic value to a Q wave? An ASSENT 2 electrocardiographic substudy. Am Heart J 2003; 146:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/25\">",
"      Andrews J, French JK, Manda SO, White HD. New Q waves on the presenting electrocardiogram independently predict increased cardiac mortality following a first ST-elevation myocardial infarction. Eur Heart J 2000; 21:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/26\">",
"      Askenazi J, Parisi AF, Cohn PF, et al. Value of the QRS complex in assessing left ventricular ejection fraction. Am J Cardiol 1978; 41:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/27\">",
"      Palmeri ST, Harrison DG, Cobb FR, et al. A QRS scoring system for assessing left ventricular function after myocardial infarction. N Engl J Med 1982; 306:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/28\">",
"      Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44:E1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/29\">",
"      de Lemos JA, Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 2001; 38:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/30\">",
"      Angeja BG, Gunda M, Murphy SA, et al. TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging. Circulation 2002; 105:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/31\">",
"      Schr&ouml;der K, Wegscheider K, Zeymer U, et al. Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction. Lancet 2001; 358:1479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/32\">",
"      Shah A, Wagner GS, Califf RM, et al. Comparative prognostic significance of simultaneous versus independent resolution of ST segment depression relative to ST segment elevation during acute myocardial infarction. J Am Coll Cardiol 1997; 30:1478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/33\">",
"      Assali A, Sclarovsky S, Herz I, et al. Persistent ST segment depression in precordial leads V5-V6 after Q-wave anterior wall myocardial infarction is associated with restrictive physiology of the left ventricle. J Am Coll Cardiol 2000; 35:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/34\">",
"      Bosimini E, Giannuzzi P, Temporelli PL, et al. Electrocardiographic evolutionary changes and left ventricular remodeling after acute myocardial infarction: results of the GISSI-3 Echo substudy. J Am Coll Cardiol 2000; 35:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/35\">",
"      Berger CJ, Murabito JM, Evans JC, et al. Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study. JAMA 1992; 268:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/36\">",
"      Furman MI, Dauerman HL, Goldberg RJ, et al. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol 2001; 37:1571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/37\">",
"      Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA 1999; 281:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/38\">",
"      Cannon CP, McCabe CH, Stone PH, et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol 1997; 30:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/39\">",
"      Kaul P, Fu Y, Chang WC, et al. Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network. J Am Coll Cardiol 2001; 38:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/40\">",
"      Mueller C, Neumann FJ, Perach W, et al. Prognostic value of the admission electrocardiogram in patients with unstable angina/non-ST-segment elevation myocardial infarction treated with very early revascularization. Am J Med 2004; 117:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/41\">",
"      Savonitto S, Cohen MG, Politi A, et al. Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes. Eur Heart J 2005; 26:2106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/42\">",
"      Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344:1879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/43\">",
"      Diderholm E, Andr&eacute;n B, Frostfeldt G, et al. ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease; the FRISC II ECG substudy. The Fast Revascularisation during InStability in Coronary artery disease. Eur Heart J 2002; 23:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/44\">",
"      Alexander JH, Harrington RA, Bhapkar M, et al. Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes. Am J Med 2003; 115:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/45\">",
"      Schechtman KB, Capone RJ, Kleiger RE, et al. Risk stratification of patients with non-Q wave myocardial infarction. The critical role of ST segment depression. The Diltiazem Reinfarction Study Research Group. Circulation 1989; 80:1148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/46\">",
"      Collinson J, Bakhai A, Taneja A, et al. Admission ECG predicts long-term outcome in acute coronary syndromes without ST elevation. QJM 2006; 99:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/47\">",
"      Holmvang L, L&uuml;scher MS, Clemmensen P, et al. Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease (A thrombin inhibition in myocardial ischemia [TRIM] substudy). The TRIM Study Group. Circulation 1998; 98:2004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/48\">",
"      Barrab&eacute;s JA, Figueras J, Moure C, et al. Prognostic significance of ST segment depression in lateral leads I, aVL, V5 and V6 on the admission electrocardiogram in patients with a first acute myocardial infarction without ST segment elevation. J Am Coll Cardiol 2000; 35:1813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/49\">",
"      Holmvang L, Clemmensen P, Lindahl B, et al. Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment. J Am Coll Cardiol 2003; 41:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/26/4521/abstract/50\">",
"      Haim M, Hod H, Kaplinsky E, et al. Frequency and prognostic significance of high-degree atrioventricular block in patients with a first non-Q-wave acute myocardial infarction. The SPRINT Study Group. Second Prevention Reinfarction Israeli Nifedipine Trial. Am J Cardiol 1997; 79:674.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2110 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-0E8BE10A25-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4521=[""].join("\n");
var outline_f4_26_4521=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16895552\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL ISSUES OF RISK STRATIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      STEMI VERSUS NSTEMI AND UNSTABLE ANGINA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ECG FOR PROGNOSIS IN STEMI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Extent of myocardial injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Anterior MI",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Inferior MI",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - QRS morphology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Presence or absence of new Q waves",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      R waves",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Resolution of ST and T wave changes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - ST segment elevation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - ST segment depression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - T wave inversion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Conduction abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ECG FOR PROGNOSIS IN UA AND NSTEMI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ST segment depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      T wave inversion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Extent of myocardial ischemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      AV block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      New Q waves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16895552\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/2110\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/2110|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/59/10174\" title=\"figure 1A\">",
"      ST segment resolution and mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/0/7182\" title=\"figure 1B\">",
"      Prognosis of MI in relation to ST changes at 90 minutes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/35/33341\" title=\"figure 2\">",
"      Survival in acute coronary syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/12/21710\" title=\"figure 3\">",
"      Relationship between ST depression and mortality unstable angina",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?27/53/28497?source=related_link\" title=\"calculator 1\">",
"      Calculator: Thrombolysis in Myocardial Infarction (TIMI) score for ST elevation acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?5/34/5665?source=related_link\" title=\"calculator 2\">",
"      Calculator: Thrombolysis in Myocardial Infarction (TIMI) score for unstable angina or non ST elevation myocardial infarction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/11/4282?source=related_link\">",
"      Conduction abnormalities after myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29722?source=related_link\">",
"      Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=related_link\">",
"      Electrocardiogram in the diagnosis of myocardial ischemia and infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44361?source=related_link\">",
"      Epidemiology of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/38/7786?source=related_link\">",
"      Fibrinolytic (thrombolytic) agents in acute ST elevation myocardial infarction: Markers of efficacy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/24/20874?source=related_link\">",
"      Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/20/4426?source=related_link\">",
"      Management of left main coronary artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/0/36868?source=related_link\">",
"      Pathogenesis and diagnosis of Q waves on the electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/46/16106?source=related_link\">",
"      Primary percutaneous coronary intervention in acute ST elevation myocardial infarction: Determinants of outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25754?source=related_link\">",
"      Risk factors for adverse outcomes after unstable angina or non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/43/2746?source=related_link\">",
"      Risk stratification after unstable angina or non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/52/35658?source=related_link\">",
"      Risk stratification for cardiac events after acute ST elevation myocardial infarction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_26_4522="Pulm AVM Brain CT";
var content_f4_26_4522=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F81070%7EPULM%2F72468%7EPULM%2F62261%7EPULM%2F72937&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F81070%7EPULM%2F72468%7EPULM%2F62261%7EPULM%2F72937&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Patient with an arteriovenous malformation in right lower lobe who developed a stroke",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 358px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A CT scan of the brain shows a right-sided ischemic stroke in the middle cerebral artery territory.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Arteriovenous malformation in right lower lobe in patient who developed a stroke",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 311px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A chest radiograph shows a feeding artery and draining vein in the right lower lobe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Arteriovenous malformation in right lower lobe in patient who developed a stroke",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 295px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A CT scan confirms a tangle of vessels in right lower lobe and draining vein coursing towards left atrium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Arteriovenous malformation in right lower lobe in patient who developed a stroke",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A CT scan confirms a tangle of vessels in right lower lobe and draining vein coursing towards left atrium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4522=[""].join("\n");
var outline_f4_26_4522=null;
var title_f4_26_4523="Differential dx CNS TB";
var content_f4_26_4523=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F69843&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F69843&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of central nervous system tuberculosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Fungal meningitis (cryptococcosis, histoplasmosis, blastomycosis, coccidioidomycosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Viral meningoencephalitis (herpes simplex, mumps)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parameningeal infection (sphenoid sinusitis, brain abscess, spinal epidural abscess)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Partially treated bacterial meningitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurosyphilis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neoplastic meningitis (lymphoma, carcinoma)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurosarcoidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurobrucellosis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4523=[""].join("\n");
var outline_f4_26_4523=null;
var title_f4_26_4524="Required purification processes";
var content_f4_26_4524=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F78701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F78701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Purification processes required to reduce contaminant levels by different amounts",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Group",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Reduction ratio",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        0-1",
"       </td>",
"       <td class=\"subtitle2\">",
"        1-10",
"       </td>",
"       <td class=\"subtitle2\">",
"        10-100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        A",
"       </td>",
"       <td>",
"        No treatment",
"       </td>",
"       <td>",
"        RO",
"       </td>",
"       <td>",
"        RO + DI or DI or Two-stage RO",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        B",
"       </td>",
"       <td>",
"        No treatment",
"       </td>",
"       <td>",
"        RO",
"       </td>",
"       <td>",
"        Carbon + RO or Two-stage RO",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        C",
"       </td>",
"       <td>",
"        No treatment",
"       </td>",
"       <td>",
"        DI or RO",
"       </td>",
"       <td>",
"        RO + DI or DI or Two-stage RO",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        D",
"       </td>",
"       <td>",
"        No treatment",
"       </td>",
"       <td>",
"        Softener or RO",
"       </td>",
"       <td>",
"        Softener + RO or DI or Softener",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        E",
"       </td>",
"       <td>",
"        No treatment",
"       </td>",
"       <td>",
"        Carbon",
"       </td>",
"       <td>",
"        Carbon",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Purification processes based upon required reduction ratios. Appropriate purification processes are selected using the maximum reduction ratio for each contaminant group. For the example given in Table A, Group A requires reverse osmosis (reduction ratio of 9.5 for fluoride); Group B requires no treatment (reduction ratio of 0.5 for mercury); Group C requires reverse osmosis or deionization (reduction ratio of 4.0 for aluminum); Group D requires softening, with or without reverse osmosis, or deionization (reduction ratio of 31 for calcium); and Group E requires carbon filtration (reduction ratio of 21 for total chlorine). This list can then be used to select a final purification cascade.",
"    <div class=\"footnotes\">",
"     RO: reverse osmosis; DI: deionization.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4524=[""].join("\n");
var outline_f4_26_4524=null;
var title_f4_26_4525="OI radiographic features";
var content_f4_26_4525=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73256&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73256&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Radiographic findings of osteogenesis imperfecta by type",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severity",
"       </td>",
"       <td class=\"subtitle1\">",
"        Skull",
"       </td>",
"       <td class=\"subtitle1\">",
"        Back",
"       </td>",
"       <td class=\"subtitle1\">",
"        Extremities",
"       </td>",
"       <td class=\"subtitle1\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"       <td>",
"        Wormian bones",
"       </td>",
"       <td>",
"        Codfish vertebrae (adults)",
"       </td>",
"       <td>",
"        Thin cortices",
"       </td>",
"       <td>",
"        Osteopenia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        Perinatal lethal",
"       </td>",
"       <td>",
"        Undermineralization; plaques of calcification",
"       </td>",
"       <td>",
"        Platyspondyly",
"       </td>",
"       <td>",
"        Severely deformed; broad, crumpled, bent femurs",
"       </td>",
"       <td>",
"        Small beaded ribs are pathognomonic of IIA; pectus excavatum (IIB)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        Severe",
"       </td>",
"       <td>",
"        Wormian bones; frontal bossing; micrognathia",
"       </td>",
"       <td>",
"        Codfish vertebrae; kyphoscoliosis; platyspondyly",
"       </td>",
"       <td>",
"        Flared metaphyses (\"popcorn-like\" appearance [childhood]), bowing, thin cortices",
"       </td>",
"       <td>",
"        Thin ribs, severe osteoporosis by DEXA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        Moderate/mild",
"       </td>",
"       <td>",
"        &plusmn; Wormian bones",
"       </td>",
"       <td>",
"        Codfish vertebrae",
"       </td>",
"       <td>",
"        Thin cortices",
"       </td>",
"       <td>",
"        Protrusio acetabuli",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        V",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"       <td>",
"        Relative macrocephaly; wormian bones",
"       </td>",
"       <td>",
"        Mild to moderate scoliosis",
"       </td>",
"       <td>",
"        Hypertrophic callus, usually of the femurs; mineralization of the interosseous membrane in the forearm; radio-opaque metaphyseal bands adjacent to growth-plates",
"       </td>",
"       <td>",
"        Severe osteoporosis by DEXA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VI",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"       <td>",
"        Wormian bones",
"       </td>",
"       <td>",
"        Compression fractures; scoliosis",
"       </td>",
"       <td>",
"        Similar to OI type IV; bulbous metaphyses",
"       </td>",
"       <td>",
"        Severe osteoporosis by DEXA; coxa vara; protusio acetabuli",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VII",
"       </td>",
"       <td>",
"        Moderate/severe/lethal",
"       </td>",
"       <td>",
"        Often small head circumference; wormian bones",
"       </td>",
"       <td>",
"        Severe scoliosis",
"       </td>",
"       <td>",
"        Could be similar to OI type IV; severely undertubulated long bones",
"       </td>",
"       <td>",
"        Rhizomelic shortening; osteopenia; coxa vara",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VIII",
"       </td>",
"       <td>",
"        Lethal/severe",
"       </td>",
"       <td>",
"        Open sutures; normal to small head circumference",
"       </td>",
"       <td>",
"        Severe scoliosis; could be similar to OI type II/III",
"       </td>",
"       <td>",
"        Undertubulated long bones; popcorn calcifications",
"       </td>",
"       <td>",
"        Severe osteoporosis by DEXA; thin ribs; barrel-shaped chest; rhizomelia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IX",
"       </td>",
"       <td>",
"        Lethal/severe/moderate",
"       </td>",
"       <td>",
"        Wormian bones",
"       </td>",
"       <td>",
"        Kyphoscoliosis; may not have compression fractures; range of skeletal features similar to OI type II/III/IV",
"       </td>",
"       <td>",
"        Bowed limbs",
"       </td>",
"       <td>",
"        Pectus carinatum; pectus excavatum; moderate to severe osteoporosis by DEXA",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified and updated from: Steiner RD, Pepin MG, Byers PH. Osteogenesis Imperfecta. GeneReviews at GeneTests: Medical Genetics Information Resource, January 2005.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4525=[""].join("\n");
var outline_f4_26_4525=null;
var title_f4_26_4526="L monocytogenes motility";
var content_f4_26_4526=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F55443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F55443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Listeria monocytogenes motility",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 206px; height: 366px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Test for motility of Listeria monocytogenes in semi-solid agar. L. monocytogenes is motile, as can be seen by the growth spreading outward from the central stab.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4526=[""].join("\n");
var outline_f4_26_4526=null;
var title_f4_26_4527="Gonococcal membrane components";
var content_f4_26_4527=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F63651&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F63651&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Components of gonococcal membrane",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 184px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_26_4527=[""].join("\n");
var outline_f4_26_4527=null;
